Mechanics of Atherosclerosis, Hypertension Induced Growth, and Arterial Remodeling by Hayenga, Heather Naomi
  
 
 
MECHANICS OF ATHEROSCLEROSIS, HYPERTENSION INDUCED GROWTH, 
AND ARTERIAL REMODELING 
 
 
A Dissertation 
by 
HEATHER NAOMI HAYENGA  
 
 
Submitted to the Office of Graduate Studies of 
Texas A&M University 
in partial fulfillment of the requirements for the degree of  
DOCTOR OF PHILOSOPHY 
 
 
May 2011 
 
 
Major Subject: Biomedical Engineering 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Mechanics of Atherosclerosis, Hypertension Induced Growth, and Arterial Remodeling 
Copyright 2011 Heather Naomi Hayenga  
  
 
 
MECHANICS OF ATHEROSCLEROSIS, HYPERTENSION INDUCED GROWTH, 
AND ARTERIAL REMODELING 
 
A Dissertation 
by 
HEATHER NAOMI HAYENGA  
 
Submitted to the Office of Graduate Studies of 
Texas A&M University 
in partial fulfillment of the requirements for the degree of  
DOCTOR OF PHILOSOPHY 
 
Approved by: 
Chair of Committee,  James E. Moore, Jr. 
Committee Members, Fred J. Clubb 
 Roland R. Kaunas 
 Alvin T. Yeh 
Head of Department, Gerald L. Cote 
 
May 2011 
 
Major Subject: Biomedical Engineering 
 iii 
ABSTRACT 
 
Mechanics of Atherosclerosis, Hypertension Induced Growth,  
and Arterial Remodeling. (December 2010) 
Heather Naomi Hayenga, B.S., University of California, Davis 
Chair of Advisory Committee: Dr. James E. Moore, Jr. 
 
In order to create informed predictive models that capture artery dependent 
responses during atherosclerosis progression and the long term response to hypertension, 
one needs to know the structural, biochemical and mechanical properties as a function of 
time in these diseased states. In the case of hypertension more is known about the 
mechanical changes; while, less is known about the structural changes over time. For 
atherosclerotic plaques, more is known about the structure and less about the mechanical 
properties. We established a congruent multi-scale model to predict the adapted salient 
arterial geometry, structure and biochemical response to an increase in pressure. 
Geometrical and structural responses to hypertension were then quantified in a 
hypertensive animal model. Eventually this type of model may be used to predict 
mechanical changes in complex disease such as atherosclerosis. Thus for future 
verification and implementation we experimentally tested atherosclerotic plaques and 
quantified composition, structure and mechanical properties. 
Using the theoretical models we can now predict arterial changes in biochemical 
concentrations as well as salient features such as geometry, mass of elastin, smooth 
 iv 
muscle, and collagen, and circumferential stress, in response to hemodynamic loads. 
Using an aortic coarctation model of hypertension, we found structural arterial responses 
differ in the aorta, coronary and cerebral arteries. Effects of elevated pressure manifest 
first in the central arteries and later in distal muscular arteries. In the aorta, there is a loss 
and then increase of cytoskeleton actin fibers, production of fibrillar collagen and 
elastin, hyperplasia or hypertrophy with nuclear polypoid, and recruitment of 
hemopoeitic progenitor cells and monocytes. In the muscular coronary, we see similar 
changes albeit it appears actin fibers are recruited and collagen production is only 
increased slightly in order to maintain constant the overall ratio of ~55%. In the 
muscular cerebral artery, despite a temporary loss in actin fibers there is little structural 
change. Contrary to hypertensive arteries, characterizing regional stiffness in 
atherosclerotic plaques has not been done before. Therefore, experimental testing on 
atherosclerotic plaques of ApoE-/- mice was performed and revealed nearly 
homogenously lipidic plaques with a median axial compressive stiffness value of 1.5 
kPa.  
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CHAPTER I 
INTRODUCTION 
 
Arterial cells sense both their mechanical and chemical environments, and they 
respond in ways that are essential for developing, maintaining, or adapting many aspects 
of tissue structure and function [1-4]. In order to create informed predictive models that 
capture and eventually predict arterial responses during hypertension and the progression 
of diseases such as atherosclerosis, one must understand the underlying structure and 
mechanical properties, and how they may change as a function of time. This motivated, 
in part, the need to build a predictive model of arterial growth and remodeling in 
response to hypertension based on data in the literature. Developing predictive models of 
arterial growth and remodeling revealed a need for additional data, particularly on the 
time course of structural arterial remodeling. Motivated by this need, arteries from a 
porcine model of hypertension were examined histologically over a growth and 
remodeling time course of 8 weeks. Significant intimal thickening was observed in the 
aorta and coronary arteries, but not cerebral arteries. Motivated by an interest in the 
mechanical properties of intimal lesions, particularly atherosclerotic plaques, and 
provoked by a lack of direct characterization of regional plaque properties, plaques from 
the aorta of mice were tested mechanically and characterized histologically. The overall 
goal of this work, therefore, is to begin to fill the gaps in our understanding of the 
mechanobiology of hypertension, an important risk factor for many cardiovascular  
____________ 
This dissertation follows the style of Atherosclerosis. 
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diseases, and in the mechanics of atherosclerosis, an underlying cause of diverse organ 
damage. 
Chapter II serves as an overview of biochemical and biomechanical vascular 
events involved in vascular remodeling due to hypertension and atherosclerosis - in 
particular, cell mechanics and resulting responses. The porcine coarctation and mouse 
apolipoprotein E knock out (ApoE -/-) animal models used herein are also described.   
 In Chapter III, we propose a new theoretical approach for incorporating cell 
level information within a tissue level model to predict mechanical and chemical 
responses by arteries. Chapter IV takes the model a step further to predict general 
mechanobiological responses in hypertension.   
In Chapter V, we characterize pressure-induced structural changes over an 8 
week period through quantification of arterial geometry and cellular composition in the 
proximal aorta, left anterior descending artery, and middle cerebral artery from a porcine 
aortic coarctation induced model of hypertension. These results are compared to our 
multiscale modeling based predictions of the salient changes of arteries in response to 
hypertension. 
In Chapter VI, regional mechanical properties of advanced plaques from an 
ApoE-/-  mouse model are characterized using atomic force microscopy (AFM). 
Understanding the mechanics of and factors involved in structural properties of lesions 
could lead to strategies to stabilize atherosclerotic plaques and to prevent plaque rupture 
through lesion-specific interventions.  
Lastly, Chapter VII summarizes the major contributions of this work.  
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CHAPTER II 
BACKGROUND AND SIGNIFICANCE: VASCULAR REMODELING 
The main conduits for blood flow include arteries, arterioles, capillaries, venules, 
and veins. Although the primary function of an artery is to carry blood away from the 
heart, the microstructure of the arterial wall can vary significantly according to location 
within the arterial tree as well as with local hemodynamics, age, and disease. 
Nonetheless, arteries are roughly categorized as elastic or muscular. The elastic arteries 
tend to have more elastin, a larger diameter, and be located closer to the heart. 
Regardless of type, all arteries consist of 3 layers: an intima, media and adventitia [Fig. 
2.1].  
 
 
 
FIGURE 2.1. Schematic of an elastic artery showing the 3 layers, and detailing the 
major constituents and their general orientation in each layer [5].  
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The intima typically consists of a monolayer of endothelial cells residing on a 
thin basal lamina (about 80 nanometers). The endothelial cells are characteristically 
oriented in the direction of flow (axially). The basal lamina is a net-like mesh consisting 
primarily of collagen IV, laminin, fibronectin, and proteoglycans. Connected to the basal 
lamina is the internal elastic lamina (IEL). The IEL is a fenestrated sheet of elastin (pore 
size about 2 to 7 micrometers) that allows transmural passage of water, nutrients, and 
electrolytes. 
 The media is primarily comprised of collagen (types I, III, and V), elastin, 
smooth muscle cells, and a ground substance matrix. The distribution and amounts of 
these constituents vary depending on the type of artery and obviously, species. For 
example, elastic arteries such as the human aorta may have up to 70 concentric layers of 
smooth muscle (each about 5 to 15 micrometers thick) separated by fenestrated sheets of 
elastic lamina (each about 3 micrometers thick). Muscular arteries, in contrast, tend to 
have only an internal elastic lamina and an external elastic lamina; cerebral arteries are 
an exception for they only have an IEL. Previous studies suggest that the number of 
lamellar units (i.e. elastic lamina and adjacent SMC layer) in elastic arteries is 
proportional to the tensile forces within the wall [6-8]. Contraction of SMCs in the 
media endows the wall with a vascular tone, which affects both stiffness and caliber. The 
interconnected collagen and smooth muscle cells are often oriented at a slight helical 
pitch from the circumferential direction. Biomechanically, this preferred orientation 
allows the contraction of the smooth muscle cells to better regulate the diameter and 
flow, especially in small muscular arteries. The elastin allows the vessel to recoil 
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elastically after each pressure pulse, and the collagenous helix allows the vessel to resist 
loads in the longitudinal and circumferential directions. 
 The outermost layer, or adventitia, is comprised primarily of fibroblasts, vasa 
vasorum, admixed elastin, collagen type I, and nerve bundles. Unlike the media, these 
collagen fibers tend to be oriented in the axial direction and to be slightly undulated. The 
adventitia makes up about 50% of the wall in muscular arteries and about 10% of the 
wall in elastic arteries. Due to the diffusion limit of nutrients and oxygen, the vasa 
vasorum serves as a means to get these elements to the outer portion of larger arteries.  
It is well accepted that an increase of internal pressure during hypertension leads 
to wall thickening [Fig. 2.2 (A, B)], which in turn restores the increased circumferential 
stress toward normal [9]; what remains a bit unclear is from where does the accumulated 
mass originate. The original hypothesis, which is still held by some today, was that 
medial hyperplasia of vascular smooth muscle constitutes the increase in wall thickness 
[10-12]. Since then, through transplant vasculopathy, several researchers have reported a 
host bone marrow cell origin of neointimal SMCs [13]. In vitro studies have also shown 
endothelial cells (ECs), when cultured with transforming growth factor beta (TGF-β), 
transdiffereniate into a SMC like phenotype expressing α-actin and lose the EC factor 
VIII antigen expression [14, 15]. Still others have found leukocytes present in the 
adventitia of hypertensive models [16].
 
These more recent findings have reformed our 
thinking of wall thickening due to hypertension. Yet there is much to be resolved 
regarding to what degree local and circulating cells contribute to neo-intimal as well as 
overall wall thickening over time as hypertension progresses.  
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On the other hand plaque development has been well classified.  Genesis 
typically starts with a fatty streak of foam cells. Some fatty streaks continue to 
accumulate lipid, smooth muscles cells (SMC), connective tissue and extracellular 
matrix proteins, growing into raised lesions [Fig. 2.2 (C, D)].  
 
 
 
FIGURE 2.2. (A, B) Pig coronary and (C, D) mouse abdominal aorta undergo 
significant structural changes from (A, C) normal to (B, D) perturbed states in response 
to their mechanobiological environment. (B) In a coarction model of hypertension a 
neointima forms that is nearly uniform in radial thickness neointima forms. (D) In an 
ApoE-/- model of atherosclerosis eccentric atheromas form. Red indicates smooth mucle 
actin, blue indicates nuclei, and green indicates elastin. 
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Animal Models 
Aortic Coarctation. An experimental method to stimulate hypertension is to place 
a balloon-expandable occluder around the thoracic aorta and inflate it until the mean 
arterial pressure is above 150 mmHg. In this model, 30 days after the target pressure is 
reached, the renin and aldosterone levels are not significantly different from the 
preocclusion levels [17]. This experimental model is similar to a congenital heart defect 
called “Coarctation of the Aorta” (CoA). CoA is most likely caused by eccentric 
hyperplasia during ductus arteriosus closure and affects roughly 1 out of every 10,000 
people [18]. The aorta may be constricted locally or, more commonly, a long segment of 
the aorta is narrowed. If untreated, CoA has a poor prognosis with 25% mortality by age 
20 years, 50% by age 35 years, 75% by age 46 years, and 90% by age 50 years [19, 20]. 
Studies show that patients with CoA have hypertension [20] along with a 5-fold increase 
in the likelihood of intracranial aneurysm [18], left ventricle hypertrophy [21], and aortic 
aneurysms. Deaths are primarily due to intracranial hemorrhage, coronary artery disease, 
congestive heart failure, or ruptured aortic aneurysms [22]. It has been established that 
aortic stenosis due to coarctation causes adverse reactions in the arterial system, but the 
exact mechanisms controlling spatial and temporal development of the stenosis are still 
unknown.  
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ApoE Knockout Mice. One of the most widely used animal models for studying 
atherosclerosis is the genetically engineered homozygous Apolipoprotein E-deficient 
(ApoE-/-) mouse (Jackson Laboratories, Maine, USA). These mice have a higher than 
normal concentration of LDL in their blood (~400 mg/dL vs 85 mg/dL). Therefore, more 
LDL is available to diffuse into and remain within the vessel wall, especially in areas of 
flow recirculation. In addition, more LDL increases blood viscosity, which contributes to 
a prolonged exposure of the endothelium to atherogenic particles [23]. Thus these mice 
accelerate the atherosclerotic process, with reported advanced eccentric lesions 
consisting of large necrotic cores, abundant fibrous tissue, lipid-laden foam cells, smooth 
muscle cells, calcification, and cholesterol clefts in the abdominal aorta at 30 weeks [24, 
25]. Many studies have shown that the atherosclerotic lesions in ApoE-/- mice 
histologically and pathologically resemble all known stages of atherosclerosis found in 
humans [24-26]. Moreover, the aortic pulse wave velocity is higher in the ApoE-/- 
compared to the wild type, which is indicative of aortic stiffening, which has been 
observed in humans with atherosclerosis [27].   
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CHAPTER III 
THEORETICAL FRAMEWORK 
Overview 
Initial observations of vascular diseases in the clinical setting are made primarily 
at the tissue level [28]. For example, using noninvasive medical imaging, clinicians can 
detect local changes in luminal diameter or wall thickness. The artery may be thickened 
due to hypertension, stenosed due to an atherosclerotic plaque, or dilated due to an 
aneurysm. Combining luminal diameter with information on local pressure (e.g., via 
tonometry or invasive transducers) can allow one to infer the degree of arterial stiffening 
due to hypertension or aging. Nevertheless, increased detail on the arterial behavior, 
based on information on geometry and applied loads, requires knowledge of the 
associated constitutive relations. These constitutive relations can be formulated to yield 
mechanically motivated (e.g., stress-strain) and/or biologically motivated (e.g., dose 
response) relationships. Toward this end, we submit that combining a tissue-level 
constrained mixture model (CMM) with a cell-level agent based model (ABM) 
represents one possible step toward the ultimate goal of multi-scale modeling of the 
vasculature wherein manifestations of disease at a clinical level can be understood in 
terms of underlying mechanisms at the cell biological level. Moreover, by ensuring 
congruency between these two otherwise disparate types of models, each motivated 
differently by and built upon different types of data, can help increase the robustness of 
our modeling. Herein, therefore, we review a particular CMM and ABM, the data upon 
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which they are based, and how one can increase confidence in their use in multi-scale 
modeling by comparing common metrics between two exclusive models.   
Introduction 
Continuum biomechanics is well suited for relating measurable blood pressures 
and flows to the stresses and strains within the arterial wall in a way that often correlates 
well with pathogenesis and disease progression, but it not well-suited for describing the 
underlying molecular and cellular level mechanobiological and biochemical responses. 
We thus suggest a new method to integrate a continuum based constrained mixture 
model (CMM) for the tissue level and an agent based model (ABM) for the cellular 
level, and we introduce a new paradigm for multi-scale modeling that can enable a new 
iterative level of model verification. Briefly, application of the continuum based mixture 
models to growth mechanics are typically founded on in vivo or in vitro data from intact 
vessels wherein information relating to individual cells or proteins is averaged over 
representative volumes, hence yielding lumped parameter type models; in contrast, 
application of algorithmic agent based models is typically founded on in vitro data from 
cell cultures or isolated cells wherein responses resulting from natural in vivo cell-cell or 
cell-matrix interactions are lost, hence yielding well defined results with less physiologic 
meaning. Although these models typically focus on different types of quantities and 
responses, they can and should have some areas of overlap. We suggest that such 
overlaps should be exploited – that is, by ensuring congruency between models 
formulated for different spatial and temporal scales, based on inherently different types 
of data, each model may in turn be expected to more faithfully reflect salient behaviors 
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of the actual biological system and together offer more reliable predictive capability. 
Herein, we illustrate predictions by both the CMM and ABM under homeostatic 
conditions. Keeping in mind the models were designed for future implementation under 
altered hemodynamics wherein congruency checks are commended. Therefore, in 
Chapter IV we illustrate the divergent response of both models under hypertensive 
conditions and introduce a novel congruency check in model verification.  
Studies initiated in the 1970s and 1980s revealed that individual vascular cells 
are highly responsive to changes in their mechanical environment, thus giving rise to the 
field of vascular mechanobiology. For example, Leung et al. (1976)[29] showed that 
increased cyclic stretch (or stress) caused vascular smooth muscle cells to increase their 
production of collagen and proteoglycans. This finding is consistent with the increased 
deposition of extracellular matrix in the thickened aortic wall in hypertension, and in 
hindsight, consistent with current thinking that increased pulse pressure (i.e., associated 
cyclic stress or strain) correlates well with changes manifested by the arterial wall (see 
[30, 31]). Similar studies on endothelial cells revealed that they change their production 
of diverse molecules (e.g., vasoactive, mitogenic, proteolytic, inflammatory) in response 
to changes in wall shear stress (see [32, 33]). Again, changes differed in some cases 
between steady and pulsatile stimuli (see [34, 35]), thus suggesting the importance of the 
latter. See Humphrey (2008) [36] for a review of diverse data that collectively suggest 
the existence of a cell-mediated mechanical homeostasis across multiple length and time 
scales in the vasculature. 
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 Whereas early “kinematic growth” models described consequences of arterial 
adaptations, Humphrey and Rajagopal (2003) [37] suggested that there was a need for a 
theoretical framework motivated by the mechanisms by which cells actually grow and 
remodel a tissue in response to altered mechanical loads. Toward that end, they 
introduced the concept of a constrained mixture wherein the equations of continuum 
biomechanics are augmented by three classes of constitutive relations that together 
account for the production and removal at different rates of individual structurally 
significant constituents, which in turn can have separate natural (stress-free) 
configurations and material properties. Implementations of this basic theory of growth 
and remodeling (G&R) have predicted salient characteristics of diverse arterial 
adaptations [38-42]. Nevertheless, all prior implementations of this approach employ 
“lumped parameter” models of production and removal.  
 Recalling the observations of Leung et al. (1976) [29], that increased cyclic 
stretch of vascular smooth muscle cells increases their production of collagen, Li et al. 
(1998) [43] extended this study to show that such production could be blocked via an 
antagonist to angiotensin II (ANG-II), an inhibitor of the angiotensin I convertor enzyme 
(ACE), or both, which in turn resulted in a decreased production of transforming growth 
factor (TGF-1) that either directly or via connective tissue growth factor (CTGF) 
altered the production of collagen. In other words, complex mechano-chemo-biological 
responses at the molecular level govern cell-mediated adaptations at tissue levels. 
Increasingly sophisticated models should thus be able to include such biological 
complexity at multiple scales. 
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 Agent based models enable one to study complex, coupled mechano-chemo-
biological responses at the cell level. Such models have been used, for example, to 
simulate a variety of adaptive responses in the vasculature, including angiogenesis in 
response to exogenously applied growth factors [44], tumor angiogenesis [45], and 
vasculogenesis [46]. All of these models represent single cells as individual “agents” that 
can exhibit realistic biological behaviors, such as proliferation, migration, 
differentiation, and apoptosis, according to a set of rules that are derived directly from 
data. Space and time are treated discretely, and emergent tissue-level responses can arise 
from collective interactions of hundreds or thousands of agents with one another and 
with their environment. The power of an ABM thus lies in its ability to represent 
individual biological cells as well as heterogeneous cell-cell interactions and its ability to 
model biologically-relevant stochasticity.  
In summary, CMMs and ABMs represent different, but complementary, 
approaches to modeling the complexity of cell-mediated, tissue-level adaptations. We 
establish herein these models in a way that capitalizes on their individual strengths and 
compensates for their individual weaknesses, which depend in part on the data sets upon 
which they are formulated. Because information at one scale can inform the other (and 
vice versa), our models were designed in such a way to eventually be able to refine 
model parameters by ensuring congruency between models while integrating multiscale 
phenomena. 
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Methods 
Our overall goal is to pursue a natural progression of mathematical modeling of 
arterial adaptations from tissue to molecular levels: classical continuum biomechanical 
analyses are essential for relating global loads (blood pressure and flow) and local 
metrics such as stress and strain. Newly developed constrained mixture models employ 
lumped-parameter expressions of cell-mediated turnover of structural constituents to 
simulate growth and remodeling at a tissue level, agent based models address discrete 
cellular activity and production of diverse molecules, and finally molecular level models 
of both the mechanics (e.g., molecular dynamic models) and the reaction kinetics (e.g., 
intracellular signaling models) permit mechanistic considerations. Herein, we focus on 
linking the first three classes of models, that is, continuum, constrained and agent based 
models. 
 Continuum Biomechanics. The five basic postulates of continuum biomechanics 
are balances of mass, linear momentum, energy, and angular momentum plus the 
entropy inequality. Whereas the first three of these relations provide the requisite 
equations of motion, the last two provide restrictions on possible constitutive relations. 
Thus, in well-posed isothermal problems, one focuses primarily on balance of mass and 
linear momentum, that can be written, in the absence of body forces, as 
    ⁄     (  )                           (3.1) 
where   is the current mass density, and v the velocity, t the Cauchy stress, and a the 
acceleration. Inertial loads are often negligible in arterial wall mechanics (Humphrey, 
2002), hence one can treat deformations during the cardiac cycle as quasi-static (i.e., let 
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a = 0). The governing equations are then closed mathematically via appropriate 
boundary conditions as well as a constitutive relation for the Cauchy stress, often written 
as 
        (    ⁄ )       ,     (3.2) 
where   is a Lagrange multiplier (which enforces isochoric motions during transient 
loading), I the identity tensor, F the deformation gradient tensor, W=W(C) the 
homogenized stored energy function,       the right Cauchy-Green tensor (which is 
properly invariant to rigid body motions), and      accounts for contributions due to 
smooth muscle contractility. Considerable research since the late 1960s has led to 
various forms of W to describe the complex, nonlinear, anisotropic behavior over finite 
strains that characterize arterial wall properties. These models are often 
phenomenological (e.g., the Fung-exponential), but nevertheless provide excellent 
approximations of the state of stress and thus considerable insight [47]. Two 
conspicuous shortcomings of classical biomechanical analyses, however, are the lack of 
attention to load bearing by individual constituents (e.g., elastin and fibrillar collagen) 
and the kinetics of G&R processes (e.g., cell and matrix turnover in evolving 
configurations). 
 Constrained Mixture Model. We will use a constrained mixture model that was 
originally written in MATLAB version 7.9.0.529 (R2009b) as a custom code by S. Baek 
and A. Valentin. CMMs build upon, but extend, classical continuum formulations. 
CMMs build upon, but extend, classical continuum formulations. Three primary 
differences involve the kinematics, the constitutive relation for the stress response, and 
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mass balance. Because classical modeling considers the arterial wall to be materially 
uniform, one only needs a single reference configuration, often taken as either unloaded 
or stress-free. In the case of a CMM, however, the wall is allowed to be materially-
nonuniform, consisting locally of different families of constituents that can each possess 
unique material properties and reference configurations that may evolve. Humphrey and 
Rajagopal (2003) [37] suggested that one refer deformations of individual constituents to 
individual natural (stress-free) configurations while requiring all constituents to deform 
with the mixture (i.e. x
k
 = x where x denotes current position). That is, constituents 
constituting the mixture are constrained to move together, hence the terminology CMM. 
Conceptually, the deformation gradient for each constituent k can then be thought of as 
               ⁄⁄  where x denotes current positions and X denotes reference 
positions. Assuming that cells tend to incorporate newly produced constituents within 
extant matrix at a preferred (target) pre-stretch or pre-stress, for which there is growing 
experimental support [48], Baek et al. (2006) [38] showed that the deformation gradient 
experienced by an individual constituent can be written as   ( )
 ( )    ( )  
  ( )  ( ) 
where s denotes the current G&R time and         denotes a past time at which the 
constituent was produced. Here,    denotes measurable deformations experienced by the 
vessel relative to a convenient original (reference) configuration and kG denotes the 
preferred “deposition stretch,” which can be prescribed. Finally, the subscript  ( ) 
reminds us that the deformation experienced by each constituent k is relative to its 
individual natural configuration defined at the time   of production. 
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 In addition, the stored energy function W in the CMM is assumed to be 
describable via a rule-of-mixtures approach, which conceptually can be thought of as 
   ∑      where    denotes a mass fraction for constituent k. Yet, to account for 
continual production and removal of different constituents within evolving stressed 
configurations, Baek et al. (2006) [38] proposed  ∑       , where 
  ( )  
(  ( )  ( )⁄ )  ( ) ̂ (  ( )
 ( ))  ∫ (  ( )  ( )⁄ )  (   ) ̂ (  ( )
 ( ))   
 
 
      
(3.3) 
where   ( ) are initial apparent mass densities (i.e., mass of constituent k per mixture 
volume) and   ( )        are evolving fractions of previously produced constituents 
that survive to current G&R time s,  ( )  ∑  ( ) is the overall mass density of the 
wall (essentially constant at 1050 kg/m
3
 independent of turnover; Rodriguez et al., 
1994),   ( )
 ( )  (  ( )
 ( ))
 
(  ( )
 ( )) is the right Cauchy-Green tensor, and   ( )  
and   (   )        represent the production rate of mass density for that constituent 
and the evolving fraction of constituents produced at time τ that survive to time s, again 
with        . Noting that     is the time at which G&R commences from a prior 
steady (homeostatic) state, the heredity integral contribution is similar to the concept of 
fading memory in nonlinear viscoelasticity; constituents contribute more to load bearing 
the more recently they were produced. Similarly, 
  ( )    ( )  ( )  ∫   ( )
 
 
  (   )  .   (3.4) 
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Examination of special cases reveals that these two evolution equations, for stored 
energy and mass density, yield desired results. For example, at s = 0, one recovers a 
standard rule-of-mixtures relation for the stored energy and the appropriate constituent 
mass density because   ( )    ( )  ( )⁄  and   ( )   ; the same is true for 
continual turnover in unchanging configurations, which we call tissue maintenance [42]. 
 Of central importance, however, are the three classes of constitutive relations 
required in this CMM: 
( )
ˆ ( ( ))k knW sC , ( )
km  , and ( ).kq s   The first class of relations 
describes elastic behaviors of individual constituents, which are reasonably well known 
(e.g., neoHookean-type behavior of elastin and exponential behavior of undulated 
fibrillar collagen); see Valentin et al. (2009) [42] for functional forms and parameter 
values. The second and third classes of relations model cell-mediated production and 
removal of individual constituents, which heretofore have been assumed to depend on 
differences in stress from their target (homeostatic) values, which is to say via lumped 
parameter models that reflect known empirical correlations. For example, one can 
consider 
  ( )        
 (    
       
    ),   (3.5) 
where the Ks are non-dimensional gain-type parameters,    (     )   ⁄ , with    a 
homeostatic target value of intramural stress (often ~ 100 kPa), and similarly for the wall 
shear stress   . This basic relationship is motivated by the aforementioned observations 
that altered intramural stress modulates the production of collagen by smooth muscle 
cells [29, 49] while shear stress regulated vasoactive molecules can hasten or slow such 
production [50, 51]. Clearly, the production rate equals its basal value as it should when 
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differences in stress from target values are zero. Note, too, that because of the use of 
normalized stress differences, it is easy to bind the associated gain parameters. For 
example, wall stress is expected to increase initially by 2- to 3-fold in hypertension 
(Humphrey, 2002) while the production rate is expected to similarly increase on the 
order of 3- to 5-fold [36]. Hence, reasonable values are   
     
           , which 
were verified parametrically by Valentin and Humphrey (2009b) [52]. 
 Similarly, we can let constituent removal be governed by an equation of the form 
  (   )    ∫   
 (    
    )  ̃
 
 ,   (3.6) 
where the K’s  are rate-type parameters having units of inverse time and   (   )  
     . Note, that if the stress equals its homeostatic value, then one simply recovers a 
simple first order decay with a rate constant   
 , which equals inverse the half-life. It is 
also interesting to note that equation (3.4), both at s = 0 and for tissue maintenance, 
provides restrictions on inter-relationships between production and removal parameters, 
namely   ( )        
   
 ⁄ , which provides another internal means of bounding 
parameter values. Finally, note that Valentin et al. (2009a) [53] show that basic 
hypotheses underlying the CMM (e.g., existence of deposition stretches and stress 
mediated turnover) are useful for capturing reported observations. In other words, 
because of the structural and biological motivation for many of the relations, there exist 
many natural bounds on parameter values that promise to facilitate future patient-
specific modeling. As noted above, however, changes in intramural stress (or strain) do 
not control the production or removal of collagen directly; for example, they can change 
the production of or responsiveness to ANG-II, which in turn affects the growth factor 
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production that controls collagen production and/or change the production or activation 
of proteases. Similarly, altered wall shear stress modulates the expression of endothelin-
1 (ET-1), which stimulates smooth muscle cell production by increasing growth factor 
production [54, 55]. Hence, although lumped parameter models representing empirically 
observed correlations are sufficient for tissue-level modeling, yielding emergent 
behaviors that reflect diverse experimental and clinical observations, there is an 
opportunity to model the underlying bio-chemo-mechanical mechanisms more directly. 
 Agent Based Model. The agent based model is primarily written in Net Logo 
version 4.1 (Wilensky, U. 1999. http://ccl.northwestern.edu/netlogo/) as a custom code 
formulated by B. Thorne and H. Hayenga. Two-dimensional ABMs can simulate the 
cross-section of an artery (at s = 0) comprised of a large number of total cells („agents‟), 
including fibroblasts (FBs), layers of smooth muscle cells (SMCs), and a monolayer of 
endothelial cells (ECs) representing the adventitial, medial, and intimal layers, 
respectively. Indeed, even invading monocytes/macrophages can be modeled 
individually. Each cell can only occupy a single pixel at any given time, however, and 
thus overlapping cells are not allowed. Each cell („agent‟) is capable of exhibiting 
behaviors characteristic of the particular cell type as well as altered behaviors in specific 
types of disease, as, for example, hypertension. These behaviors are prescribed by 
individual rules, which in turn are derived directly from data collected from diverse cell 
cultures and hence are relevant to many aspects of vascular physiology and 
pathophysiology. Table 3.1 lists illustrative cell behaviors and the rules that govern 
them. For example, SMCs may proliferate (double) or migrate (move from one pixel to 
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another). SMCs may express and secrete (produce) diverse proteins, including growth 
factors (PDGF and TGF-), extracellular matrix (collagen type-I), and proteases, 
including matrix metalloproteinase-1 (MMP-1) that can degrade collagen. Levels of 
production of these factors by an individual SMC are regulated in part by the mean 
circumferential stress that each cell experiences at a given time (see Table 3.1) or 
possibly substances produced by other cells in response to other loads. ECs are similarly 
capable of producing vasoactive molecules (e.g., ET-1 and NO), growth factors, MMPs, 
and adhesion molecules that regulate interactions between blood borne cells (e.g., 
monocytes and platelets) and the endothelium. Non-structurally significant molecules, 
such as PDGF, TGF-, MMP-1, MMP-2, MMP-9, ET-1 and NO, can diffuse locally to 
adjacent patches at a fixed rate and cause both vasoactive responses by SMCs or alter 
their production of collagen. For example, the diffusion rate for PDGF is 1%; therefore, 
at each time step, 1/8 of 1% of the total amount of PDGF at any given patch will be 
shared with each of the 8 neighboring patches. Each patch reciprocates by receiving and 
sending protein to nearby patches. The diffusion rates were arbitrarily set at a low value. 
When more specific diffusion functions are defined they can be implemented into the 
ABM. Molecules that diffuse into the luminal space are set to zero on the assumption 
that blood flow will remove locally produced proteins.  
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At each time step ECM and soluble factors are both accumulated and dissipated; 
the rate and functions for these processes is detailed in Table 3.1. For example, MMP-1 
degrades collagen to gelatin, MMP-2 and 9 then degrade gelatin to nothing. If any 
MMP-2 or 9 is left they then degrade elastin to gelatin. Currently the half-life of the 
MMPs is arbitrarily assumed to be every time step (6 hrs). However, this can be 
modified when a more accurate value is reported. In addition, ET-1 and NO are 
produced according to literature derived functions. However, these molecules are neither 
dissipated nor used in the current model. Implementing appropriate diffusion functions 
will aid in the usefulness of these vasoregulator molecules. SMC production is 
dependent on PDGF, whereas SMC removal is constrained to produce mass balance 
equilibrium in homeostatic conditions.  
Upon production and/or diffusion, it is typically assumed that 100% of the 
soluble factors bind to their respective targets (e.g., receptors or binding pockets) and 
impact cell behavior or matrix levels. For example, if a threshold level of PDGF is 
reached at a particular pixel, the chance of SMC proliferation at that discrete location 
will increase. That is, at G&R time t = s, a random number generator chooses an integer 
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TABLE 3.1. Literature derived rules that dictate the production, removal of cells and the 
surrounding matrix in the ABM. 
Behavior ABM Rule Citation 
SMC proliferation chance 100 in ( (    )   )           
           ,          pg 
[56], [57], [58] 
SMC apoptosis chance                         
Mass balance constraint 
NA 
SMC production of PDGF 
(stretch induced) 
      
          ,             pg 
[59], [60] 
SMC production of TGF
(stretch induced) 
      
          ,             pg 
[61], [62] 
SMC production of MMP-1 
(constant) 
    ( )     
t = time, b = baseline = 2.70 pg/cell/6hrs, 
a = percent active = 39.32 %  
[63], [64] 
SMC production of MMP-2 
(stretch induced) 
 ( (   (       
 
))) 
A = % active = 0.001 
M = max rate = 1 pg/cell/6hrs 
δ = 0.03, α = 0.52, κ = 2.0E-06, n = 2.84 
[65], [66] 
SMC production of MMP-9 
(stretch induced) 
 ( (   (       
 
))) 
A = % active = 0.003 
M = max rate = 0.018 pg/cell/6hrs 
δ = 0.04, α = 0.44, κ = 4.0E-06, n = 2.88 
[65], [67] 
SMC production of Collagen  
(TGFβ dependent) 
if TGFβ and PDGF-AB present, 
    β    
        ,            pg 
otherwise, 
basal production =          pg 
[68], [69], [70] 
EC production of NO 
(flow induced) 
  ̃         
    ̃           
  ̃          ̃    
  ̃    
      (   
         
    ) 
              ,               
[71] 
 
EC production of PDGF 
(flow induced) 
 (          
 
) 
M = max rate = 0.078 pg/cell/6hrs 
δ = 0.15, α = 0.84, κ = 0.42, n = 1.24 
[72], [73] 
EC production of ET-1 
(flow induced) 
 (   (       
 
)) 
M = max rate = 4.8E-03 pg/cell/6hrs 
δ = 0.60, α = 0.40, κ = 3.63, n = 1.68 
[74], [75] 
MMP-1 reduction of 
collagen to gelatin 
150 pg collagen/pg MMP-1/6hrs 
 
[76], [77] 
MMP-2 reduction of gelatin  410 pg gelatin/pg MMP-2/1hr [78], [79] 
MMP-9 reduction of gelatin  135 pg gelatin/pg MMP-9/1hr [78], [80] 
MMP-2 reduction of elastin  For remaining MMP-2, 
2.64 pg elastin/pg MMP-2/1hr 
[78], [79], [80] 
MMP-9 reduction of elastin  For remaining MMP-9, 
0.87 pg elastin/pg MMP-9/1hr 
[78], [79], [80] 
MMP-1 removal MMP-1/2/6hrs NA 
MMP-2 removal MMP-2/2/6hrs NA 
MMP-9 removal MMP-9/2/6hrs NA 
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between 0 and  (    )   , where in homeostasis this value is 80,000. If the number 
is less than 100, then the cell proliferates; if the number is larger than 100, then the SMC 
remains as is for the current time step. This process repeats for each time step in the 
simulation. To achieve proper tissue maintenance (i.e. balance production and removal 
in homeostasis) this stochasticity is also applied to the rule dictating SMC apoptosis, 
except the range in values for the random number generator varies. That is, instead of 
choosing an integer between 0 and 80,000 (in homeostasis), the integer can be chosen 
between 0 and 71,020. MMP-1 degrades collagen I, and in the ABM the total amount of 
collagen at a given pixel is reduced proportional to the concentration of MMP-1 [81]. 
Whereas the rules in Table 3.1 were derived from the literature, it is notable that in 
many cases the available data are as yet incomplete and in some cases they are 
conflicting. 
 ABM Rule Scoring. Fundamental to identifying appropriate ABM rule sets is a 
consistent strategy for data mining or experimental planning. Therefore, the quality of 
the papers underlying each rule was evaluated based on a systematic and semi-objective 
set of criteria. These criteria were based on 5 categories: (1) article agreement, (2) 
physiological methods, (3) distant metric to computational model, (4) source credibility, 
and (5) data type. That is the articles that each ABM rule is built from was rated on a 
scale of 1 to 10 according to categories 1 through 5.  For example if the value in 
question, say the baseline value of TGFβ produced by vascular SMCs is 35 pg/mL/day 
[62], is roughly agreed upon by 7 or more other sources than category (1) would receive 
a score of 10. If 5 to 6 articles agree a score of 9 is given, if 3 to 4 articles a score of 7, 1 
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to 2 articles a score of 5 and if no articles agreed with this statement a score of 0 was 
given. Category (2) measured how close the experimental system was to in-vivo, and if 
calculations were made, whether or not they accounted for nonlinearities, anisotropy and 
heterogeneity. It is important to consider how close the species, organ, cell type or 
environmental condition is to that being simulated. Therefore, category (3) was scored 
according to how close these metrics (i.e. species, organ, cell type, and environmental 
condition) were to that we were simulating (i.e. mouse, artery, either EC or SMC, and in 
vivo); where a score of 10 was given if they matched, 5 if it was close, or 0 if they were 
not similar. Factors that give credence to an article may include the journal impact 
factor, number of times the article was cited or universal acceptance of experimental 
techniques. Thus category (4) was based on these credibility measurements; however 
scores from this category were not included in the overall score because these values can 
be misleading. For example if a statement is made incorrectly it may be cited by many 
others as being flawed. Lastly, category (5) considers how accurately the data were 
acquired. If the value in question was measured directly, quantitatively, and contained a 
lot of data points it would receive a score of 10. Please refer to the caption of Table 3.2 
for a more detailed breakdown of this scoring regime. Due to the continuing lack of data, 
if the average composite score amongst 2 researchers was above 50 the rule was 
considered in the ABM. If the score was below 50, a search for other articles to 
formulate a new but similar rule was conducted. If no alternative articles were found, 
than the values that make up the rule remained but the predicted outcomes as a result of 
 26 
these rules were evaluated cautiously. In addition, these values were parameterized and 
allowed to vary within a bounded range (see Chapter IV).    
 ABM Parameter Sensitivity Analysis. In addition to scoring the confidence in the 
rules, a 1-D parameter sensitivity analysis was performed for all 37 parameters in the 
ABM. The sensitivity analysis will guide the suitable upper and lower bound for each 
parameter thereby allowing the model to be adjustable, but still predict the physiological 
behavior. Thus, an individual parameter was increased and then decreased by an order of 
magnitude while fixing all 36 other parameters at their prescribed value. Due to the 
inherent ABM stochasticity, the ABM model was run 100 times for each of these 
parameter sets. The predictions were then averaged and plotted ± the 95% confidence 
interval. If the confidence interval of the predicted results (using the initial parameter 
and the varied parameter) overlapped the predicted results (using the initial parameters) 
the model was considered to be insensitive to that parameter. However, if the confidence 
intervals did not overlap (i.e. the increase or decrease in parameters caused significant 
changes of the outputs), another, more detailed, sensitive analysis was performed. That 
is, the parameters were varied up and down by 1.5, 2, 5, and 10 times their original 
value. Again confidence intervals were calculated for the results. The maximum and 
minimum parameter change that resulted overlapping confidence intervals was deemed 
the upper and lower bound respectively, for the parameter. This sensitivity analysis 
allows us to know the range of which a single parameter can vary and still have the 
potential to give a physiological response under homeostatic conditions.    
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Model Verification and Integration 
Once formulated, each model must be verified; that is, it must be shown to yield 
expected results. With modeling arterial G&R, which is inherently a dynamic process, a 
fundamental requirement is that the model is predicatively stable. For example, in the 
absence of perturbed hemodynamic loads, the model should predict unchanging 
geometry, properties, and function due to balanced turnover in a stable configuration 
over long periods (i.e., tissue maintenance) and it should be stable against reasonable 
transient perturbations.  
 Tissue Maintenance. Both the CMM and the ABM are numerically stable under 
both baseline conditions and in response to a transient perturbation in blood pressure. In 
particular, the CMM accounts for a production of new collagen fibers and smooth 
muscle, each deposited according to individual deposition stretches and aligned 
properly, that balances removal [53]. This outcome is appreciated by observing the 
arterial response to a modest increase in pressure that lasts but one time increment (6 
hours in this case). Similarly, based on independently identified but otherwise 
interdependent rules, the ABM balances the production and removal of SMCs when the 
applied loads remain constant over extended periods. For example, although there is a 
100 out of 80,000 chance of a SMC proliferating every 6 hours but a 100 out of 71,020 
chance of SMC apoptosis every 6 hours, it is assumed that cell proliferation happens 
before apoptosis. Thus, over time, the greater chance of cell apoptosis balances out 
increases in mass due to proliferation.  
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For the illustrative example used herein – homeostatic production of collagen and 
smooth muscle in a representative mouse abdominal aorta subjected to constant flow but 
possible changes in pressure – we assumed baseline conditions whereby the overall (i.e., 
mixture) mass density is 1.05 g/cm
2
 and mass fractions for collagen, elastin, and smooth 
muscle, respectively, are 0.44, 0.28, and 0.28 [82, 83]. The ABM simulates the cross-
section of an 521.2-micron outer diameter mouse aorta (at G&R time t = 0), comprised 
of 472 total cells (“agents”) including 319 smooth muscle cells and 153 endothelial cells 
representing the medial and intimal layers, respectively. Moreover, we set the vessel be 
axisymmetric and have an average thickness of 30.6-micrometers, which results from 2 
to 4 layers of SMCs and 1 layer of endothelial cells [Fig. 3.1]. In order to simplify the 
ABM and reduce the total number of simulated cells, we excluded the adventitia, which 
is equivalent to assuming that the behaviors of the fibroblasts and extracellular matrix 
constituting this layer contribute minimally to the remodeling response relative to the 
behaviors of the smooth muscle cells and endothelial cells, which are the focus of this 
first-generation model. This constraint was applied primarily so that the ABM can match 
the structure of the CMM. However, fibroblasts have been reported to play a role in 
arterial remodeling due to vascular diseases [84]. Therefore, future generations of the 
ABM and CMM can include these cells as well as additional molecules. Each cell 
occupies a single pixel, represented as a 100 µm
2
 area, at any given time, and there are 
no overlapping cells. Likewise, at G&R time t = 0, the CMM simulates nearly the same 
initial axisymmetric mouse abdominal aorta with a 528.2-micron outer diameter and 
wall thickness of 30.1 microns [85].  
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FIGURE 3.1. Screen shot of the ABM, displaying a 2-D representation of the model 
mouse abdominal aorta on the right and user controls as well as a display of progress on 
the left. 
 
 
 
Each time step in the simulation represents six hours, and a total of one hundred 
days was simulated.  The output of the ABM at each time step includes both a graphical 
depiction of each cell [Fig. 3.1] and a text file that lists, for each pixel, the following 
information: X-coordinate, Y-coordinate, total mass of collagen, muscle, elastin, newly 
deposited collagen and muscle since the last time step, concentration of MMP-1, PDGF, 
TGF-β, NO, and ET1, and the total number of SMCs. ABM simulations were run at least 
5 times and the outputs were averaged; this was done primarily due to stochasity in the 
rules dictating SMC proliferation and apoptosis. Whereas the ABM uses an intra-
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relational rule set to balance matrix production and removal in equilibrium, with wall 
thickness depending directly on accumulation/removal of cells while the inner radius 
remains constant, the CMM uses a Newton-Raphson method to determine the inner 
radius and wall thickness of the axisymmetric artery that satisfies mechanical 
equilibrium during cell and matrix turnover. Because the two models can share some 
outputs in common, this provides a unique opportunity to compare such predictions at an 
intermediate level of computation and iteratively refine associated parameters to increase 
congruency across scales. 
Results 
Table 3.2 illustrates one representative rule governing the ABM, production of 
PDGF by SMC as a function of stretch, and the degree of inaccuracy inherent to that rule 
based on a scoring by two researchers. Confidence in the literature was achieved if 
multiple papers agreed on the findings [Table 3.2(*)], the methods were physiological 
[Table 3.2(**)], the sample was close to that being modeled, and data collection and 
representation were deemed to be accurate [Table 3.2(***)]. In this example, researcher 
1 found no supportive articles corresponding to the baseline production of PDGF by 
SMCs as found by Li et al., 1995 [59], whereas researcher 2 found 1 article. Similarly, 
researcher 1 found 4 articles [86-89] in agreement with stretch increasing SMCs 
production of PDGF [60], whereas researcher 2 found 1. Slight differences were seen in 
the other scoring categories as well, leading to different average confidence scores for 
each article. The composite score (found by averaging the scores for each article making 
up a single rule) was 52.55 for researcher 1 and 60.42 for researcher 2.  Due to inherent 
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inaccuracy to experimental testing of biological tissues, rules that had a composite 
researcher rating >50% (including the example shown here) were considered acceptable 
and implemented in the ABM. Rules that had a composite score <50% were also 
implemented into the ABM as placeholders until more accurate literature becomes 
available. In particular, the rules governing production and degradation of MMP-2 or 9 
[65-67] scored low in categories 3 and 5 resulting in an overall composite score of 
around 45. Whereas, the composite score for the rules governing the amount of gelatin 
that is degraded per hour by MMP-2 or 9 [78-80] were around 75. However, because the 
amount of MMP-2 or 9 produced and removed play such a crucial role in elastin 
degradation, the predicted values of elastin by the ABM should not be considered 
accurate until the pertaining rules are improved. 
Parameter sensitivity analysis was performed on the parameters that make up the 
acceptable rules. Figure 3.2 shows illustrative results for the parameter   in the rule for 
ET-1 production in response to wall shear stress rule. Increasing or decreasing this 
parameter by an order of magnitude results in little overall change of predicted SMC 
number, collagen mass, hoop stress, PDGF mass, and TGFβ mass over time in 
homeostatic conditions. Because the 95% confidence intervals overlapped in this case, 
the rule was deemed to be relatively insensitive to this parameter and it was fixed at the 
literature determined baseline value. That is, the model appears to be insensitive 
amongst significant fluctuations in this parameter.  
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TABLE 3.2. Example of confidence scoring regime for an ABM rule dictating how 
much PDGF is produced by a SMC as a function of hoop stress. Rubric detailing point 
ratio is mentioned below the table for categories 1, 2 and 5. Scoring was based on 4 of 
the 5 categories. Category 4 was not included in the total confidence score. If the 
category had multiple subcategories, only the average was used (e.g. 3. and 5.) to 
calculate the average confidence. The average confidence values for all the literary 
references making up a rule were then averaged to give the composite score for any 
given researcher.  
 Researcher 1 Scoring Researcher 2 Scoring 
Rule SMC production of PDGF (stress dependent) 
Relevant Papers 
  
Li et al. 
(1995) 
Ma et al. 
(1999) 
Li et al. 
(1995) 
Ma et al. 
(1999) 
1. Article agreement*
 0 7 5 5 
2. Physiological methods**
 6 4 6 6 
 3a. same species 0 0 0 0 
 3b. same organ 10 10 10 10 
 3c. same cell type 10 10 10 10 
 3d. same in vivo state 5 5 10 10 
3. Distant metric total: 6.25 6.25 7.5 7.5 
 4a. journal Impact Factor 2.06 2.55 2.06 2.55 
 4b. citations 9 32 9 32 
 4c. experimental reliability  4 3 3 3 
4. Source credibility total: 4 3 3 3 
 5a. numerical*** 10 10 10 10 
 5b. measured directly*** 7 7 5 5 
 5c. many data points*** 2 4 2 2 
5. Data type total: 6.33 7 5.67 5.67 
Average Confidence: 4.65 5.86 6.04 6.04 
Composite Score 52.55 60.42 
 
*      The number of articles in agreement to score ratio is: 0:0; 1-2: 5; 3-4: 7; 5-6: 9; 7 and 
above: 10. If there are articles in disagreement subtract from the total articles in agreement.  
 
**     If the experiment was in-vivo, accounted for nonlinearity, anisotropy, and heterogeneity: 
10; if ex-vivo, pre-conditioned, acute testing: 8; if ex-vivo, cultured, pre-conditioned: 6; if 
in-vitro, acute testing, environment like in-vivo: 4; if in-vitro, cultured: 2.   
 
***   5.a. Numerical: 10, theoretical: 6, descriptive: 2. 5.b. Measured directly: 10, measured 
indirectly: 7, extrapolated: 5, descriptive: 2. 5.c. over 20 data points: 10, 16-20 data points: 
8, 11-15 data points: 6, 6-10 data points: 4, 1-5 data points: 2. 
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FIGURE 3.2. Parameter sensitivity analysis for the parameter δ in the rule for ET-1 
production (see Table 3.1). This rule states that the production of ET-1 by ECs depends 
on wall shear stress in a sigmoid fashion. Each solid line represents the mean value 
based on 100 replications of the ABM. Blue indicates the response when the parameter 
was increased an order of magnitude, green when the parameter was decreased an order 
of magnitude, and red when the parameter remained at its original value. The pastel 
colors represent the 95% confidence intervals surrounding each result.   
 
 
 
 In cases where the confidence intervals did not overlap, an additional, more 
detailed, sensitivity analysis was performed by allowing the parameter of interest to vary 
by 1.5, 2, 5, and 10 times its original value.  Figure 3.3 shows an illustrative result for 
the sensitivity of the rule for SMC proliferation relative to its baseline value. In these 
cases, the sensitivity of the ABM to the particular parameter was noted and appropriate 
bounds were imposed to define allowable values (see Chapter IV).   
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FIGURE 3.3. Parameter sensitivity results for the baseline SMC proliferation value 
(M0). This parameter was multiplied or divided by 1.5, 2, 5, and 10 from its original 
value. Show here is only the case were it was divided.  
 
 
 
Both the ABM and CMM acurately predict normal tissue maintance under stable 
physiological conditions. That is, both the ABM and CMM simulated constant arterial 
responses to constant mean pressure amongst two 10% increases arbitrarily assigned to 
persist for 6 hours (i.e., one computational increment in time) on both days 1 and 60 
[Fig. 3.4 (A)]. The parameters used for these simulations were fixed at their initial 
values. The CMM predicted no net change in radius and mass when the pressure was 
constant. However, the transient increase in pressure resulted in a passive 0.7% increase  
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of inner radius [Fig. 3.5 (A, CMM)] and a 0.6% decrease in wall thickness [Fig. 3.5 (A, 
CMM)]. These modest changes caused a slight increase in collagen and smooth muscle 
fiber tension and decrease in wall shear stress [Fig. 3.4 (C, CMM)]. According to the 
mass production function [equation 3.5], changes from normalcy in fiber tension and 
wall shear stress caused an increased production of SMCs and collagen that manifested 
as a gradual increase up to 0.2% in SMC mass and 0.18% in collagen mass [Fig. 3.5 (C, 
D, CMM)]. Due to both the lack of elastin production past the perinatal period and its 
longterm stability (half-life ~ 35 years), it was neither produced nor removed within the 
CMM [Fig. 3.5 (E)]. As noted earlier, ABM did not predict elastin since the rules 
governing elastin production/removal are not well established. Under homeostatic 
pressure conditions with transient increases in pressure [Fig. 3.4], the chance of SMC 
proliferation and apoptosis were each nearly constant as was the hoop stress at 100 kPa, 
as predicted by the ABM. Therefore, production and removal of cells “agents” was 
balanced and there was effectively no change in matrix mass [Fig. 3.5]. 
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FIGURE 3.4. (A) A transient increase in pressure results in a transient increase in (B) 
hoop stress and decrease in (C) shear stress. The CMM predicts an acute increase in 
inner radius and associated decrease in shear stress that promote an acute thinning of the 
arterial wall, due to incompressibility. The stochastic nature of the ABM renders the 
inner radius and wall shear stress insensitive to small transient changes in pressure as 
expected. 
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FIGURE 3.5. The artery recovers its basal geometry after a transient 10% increase in 
pressure over 1 time step (6 hours). Both models maintain appropriate basal levels of 
structurally significant constituents after the transient 10% increase in pressure.  
 
 
 
Relatively speaking, it was found at the tissue level that the ABM was insensitive 
to modest changes in applied loads. At the molecular level, however, the ABM captured 
the dynamic synthesis response. That is, over the 6 hours of increased pressure, TGF-β 
increased ~26.3%, PDGF increased ~75.4%, MMP-2 increased ~14.4%, and MMP-9 
increased ~5.1% over baseline. These values were promptly returned to the basal value 
after the pressure returned to normal. MMP-1 did not increase even transiently, meaning 
that collagen-1 degradation to gelatin was not increased above normality. The increase in 
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MMP-2 and MMP-9 was not significant enough to cause removal of gelatin mass even if 
it had been created [Fig. 3.6 (F)] 
 
 
 
FIGURE 3.6. ABM predictions of the concentrations of PDGF, TGF- β, MMP-2, and 
MMP-9 show temporary increases in response to a 10 % increase in pressure over 6 
hours. Collagen and smooth muscle amounts were not altered by these increases, 
however, as seen previously (see Fig. 3.3). 
 
 
 
Discussion 
 We have presented a highly simplified representation of some of the key 
biochemical and biomechanical phenomena that drive arterial G&R in hypertension and 
that give rise to structural adaptations by the vascular wall. Our two-tiered model 
integrates inputs and outputs to and from both discrete (ABM) and continuum (CMM) 
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representations of the mechanobiology.  In so doing, our multi-scale simulation links 
single-cell behaviors with tissue-level responses and enables us to verify predictions at 
both levels of scale by quantitative cross-comparison of key output metrics. This linking 
of phenomena across spatial scales promises to enable us to study how biochemical 
phenomena at lower scales influence mechanical phenomena at higher scales and how 
biomechanical phenomena at higher scales, in turn, impact biochemical phenomena at 
lower scales. By using congruent parameter values in the CMM and ABM, where 
possible, we are also able to answer the question: “To what extent can two very different 
modeling approaches arrive at the same predictions?”  
 Presented in this chapter is a systematic and semi-objective regime for 
determining suitable rules for agent based modeling. Conflicting or inconsistent data can 
make formulating rules difficult. Therefore this general approach can be applied to guide 
other ABMs. One of the limitations to our parameter sensitivity study is the fact that we 
only varied one parameter at a time while keeping all others fixed. This was done 
primarily due to the computationally expensive nature of the ABM. That is, each 
parameter takes a little over 8 hours (i.e. each simulation takes 5 minutes and there are 
100 simulation replications) and there are 37 parameters. Therefore small changes in 
multiple parameters can potentially lead to predictions that diverge from physiological 
responses. However, the CMM has gone through a multivariable sensitivity analysis 
[52]. By comparing common predictions of the ABM and CMM through a genetic 
algorithm will allow the models to converge and predict a more physiological response. 
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This is achieved by knowing the CMM will only predict, within reason, physiological 
responses regardless of multivariable parameter combinations.  
 In conclusion, this work represents but another step toward the ultimate goal of 
developing models of the vasculature that are both descriptive and predictive, based on 
information gleaned from molecular, cellular, tissue, and organ levels. The present 
integration of the ABM and CMM represents one method of linking cellular and tissue 
levels, but there remains a need to link molecular mechanisms to cellular responses as 
well as a need to link tissue level manifestations to overall hemodynamics and transport. 
The former need may be facilitated by linking Intracellular Signaling Models (ISM), e.g. 
growth factors influence on gene regulation through the intracellular signaling pathways, 
to ABM [90]; whereas the latter may be facilitated by linking CMM with computational 
fluid dynamics (CFD) models that describe blood flow and transport in large portions of 
the vasculature [91]. Much remains to be accomplished, but rapid progress within each 
area promises future integration across scales.  
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CHAPTER IV 
HYPERTENSION – MODELING  
Overview 
Hypertension results in significant changes in composition, geometry, structure, 
and mechanical properties of arteries. To capture the intricacies of such changes, there is 
a pressing need for inclusive models that can describe and predict both the mechanics 
and the biology. Continuum based biomechanical models are well suited for relating 
measurable blood pressures and flows to local metrics such as stress and strain, but not 
for describing cellular level mechanobiological and biochemical responses. Discrete 
stochastic agent based models are well suited to capture the biological complexity at a 
cellular level, but not tissue level mechanical changes. Thus, we coupled a constrained 
mixture model (CMM) with an agent based model (ABM) to predict better both salient 
mechanical changes and biochemical phenomena occurring during the progression of 
hypertension of a representative mouse abdominal aorta. A sustained increase in 
pressure of 30% is expected to increase the expression of both growth factors and 
proteases, and thus a proliferation of smooth muscle cells and deposition of collagen that 
results, in part, in an overall increase in wall thickness in a time-dependent manner while 
maintaining constant the inner radius. Early pressure-induced adaptations are expected to 
have little effect on elastin, however. Integrating literature based mechanisms originating 
at the cellular level with observed tissue level phenomenon allows for better prediction 
of response to hypertension. 
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Introduction 
Hypertension remains a significant risk factor for many cardiovascular diseases, 
including heart failure, stroke, and end-stage renal failure. Hypertension causes, or is 
caused by, significant changes in the geometry, structure, mechanical properties, and 
function of arteries and arterioles. Because of the complexity of such changes, as well as 
their impact on the hemodynamics, there is a pressing need for increasingly inclusive 
computational models that can describe and predict both the mechanics and the biology. 
Indeed, it is increasingly realized that multi-scale models are essential for integrating 
information from the tissue/organ level, at which localized initiating diseases such as 
atherosclerosis present and are treated clinically, with information at the molecular/cell 
level, at which underlying mechanisms originate. In the previous chapter, we presented a 
new approach for integrating a tissue-level continuum mixture model (CMM) and a cell-
level agent based model (ABM) that allows one to address better both the underlying 
mechanisms of arterial adaptation to altered hemodynamics and the associated 
macroscopic manifestation that is important clinically. To illustrate the potential utility 
of this multi-scale approach, we consider here the case of cell-mediated large artery 
adaptation to a sustained increase in blood pressure that is, to hypertension. 
 Pioneering work by H. Wolinsky, S. Glagov, and others in the 1960s and 1970s 
revealed the fundamental importance of continuum mechanics in arterial wall biology in 
general and hypertension in particular. Via comparative studies across species, Wolinsky 
and Glagov (1967) showed that increased aortic wall thickness correlates well with the 
increased caliber that is necessary to accommodate increased volumetric blood flows in 
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larger animals such that wall tension per lamellar unit is nearly constant at ~ 2 N/m [8]. 
That is, it became apparent that the normal aortic wall grows and remodels during 
development and maturation so as to maintain nearly constant the mean circumferential 
stress (      ⁄ , where P is pressure, a the luminal radius, and h the wall thickness; 
[92, 93]). Indeed, this general finding is consistent with an idea that emerged in 
hemodynamics during the same period, namely, that the aortic wall grows and remodels 
so as to maintain nearly constant the mean wall shear stress (        
 ⁄ , where µ is 
viscosity and Q the volumetric flow rate [92, 94]; the particular target value of which 
varies along the vascular tree and across species [95]. Among others, Wolinsky (1971) 
[49] suggested further that thickening of the aortic wall in response to hypertension is 
similarly consistent with the concept that mean circumferential stress is maintained 
nearly constant, a finding that has been confirmed by many others [96, 97]. During 
development, changes in wall tension associated with alterations in blood pressure 
closely correspond to differences in accumulation of transmural collagen and elastin in 
the ascending aorta and pulmonary trunk [7]. These and related findings emphasize the 
importance of stress analyses in continuum biomechanics, which is perhaps best 
illustrated by the seminal finding by Chuong and Fung (1986) [98]. They showed that 
residual stresses in arteries tend to homogenize the predicted transmural distributions of 
circumferential and axial stresses, which suggests that the arterial wall not only tries to 
maintain the mean stress at a preferred value, it also tries to maintain the transmural 
distribution at this mean [99]. Diverse studies suggest that axial wall stress plays a 
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similarly fundamental role in mechanical homeostasis and thereby affects adaptations by 
arteries in response to changes in mechanical loading or genetic defects [42].  
 The 1990s brought forth a logical extension of classical continuum 
biomechanical analyses to try to describe functional adaptations. Stress-mediated 
changes in arterial geometry and properties were modeled using classical balance 
relations and constitutive relations for stress augmented with extensions for the concept 
of kinematic growth introduced by Skalak (1981) [100]. Briefly, it was assumed that 
either gross geometry (radius or thickness) or associated deformations (stretch ratios) 
evolved whenever intramural or wall shear stresses differed from target values, with 
equilibrium enforced at each evolved configuration. For example, Rachev et al. (1996) 
[101] predicted macroscopic changes in arteries due to hypertension and Taber (1998) 
[102] predicted changes in aortic development. Similar studies based on kinematic 
growth continue to capture diverse consequences of arterial adaptations [103, 104]. 
Therefore, continuum models are capable of predicting the salient features of 
hypertension, but a need for integrative models to capture the molecular and cellular 
mechanisms applied to the tissue level has been expressed by many [39, 42, 53, 105]. 
A unique approach to predict cellular adaptation to perturbations is through 
Agent Based Modeling (ABM). Agent based modeling simulates the interaction of 
autonomous agents (e.g. individual cells) with each other and their environment based 
on a literature-derived set of rules to predict emergent patterns [106]. Classically, ABM 
has been used for ecological and sociological applications. Only recently has ABM been 
widely used for biomedical applications, as detailed in the review by [106].
 
As an 
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example, leukocyte adhesion and transmigration has been modeled from over 70 
literature-based rules based upon adhesion molecule expression, soluble and surface-
bound chemokines/cytokines and flow-mediated wall shear stress [107]. After knocking 
out selectins, the model predicts a change in flow velocity leading to less integrin 
activation resulting in decreased firm adhesion of monocytes [106]. This approach 
allows for better aggregate understanding of signal pathways and molecules crucial to 
the final outcome.  
In order to create a comprehensive predictive bio-chemo-mechanical model of 
arterial growth and remodeling, one would need to consider the effects of hundreds of 
biochemically active molecules and their mechanical consequences on the arterial wall, 
and vice versa. If we restrict our consideration to the primary vasoactive, growth and 
regulatory, and proteolytic molecules, we consider NO (nitric oxide), ET-1 (endothelin-
1), TGFb (tissue growth factor-beta1), PDGF (platelet derived growth factor), and 
MMP-1, -2 and -9 (matrix metalloproteinase-1, -2 and -9). In Chapter III we created a 
model that predicts soluble molecules as well as structurally significant insoluble 
constituents while allowing the artery to evolve dynamically over time. Herein we 
extend this model unification process through re-parameterization which allows for a 
more physiological prediction of clinical observations in the classical case of 
hypertension. 
Methods 
The constrained mixture model (CMM) was first introduced in 2003 by 
Humphrey and Rajagopal [37] which builds upon the modern theory of mixtures 
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proposed in 1957 by Truesdell and Noll. Since its introduction, the CMM has been 
refined and applied as a predictive model for normal and vascular disease conditions 
[38-42, 99, 108-111]. Details of the CMM use in these simulations can be found 
elsewhere (Chapter III; [42]); herein, we will reiterate the current growth and remodeling 
kinetics. The arterial wall consists of structurally significant constituents, k, (i.e. elastin, 
collagen and SMC) that are each described by specific strain-energy density relations 
relative to their individual natural configurations and mass fractions. The mass fractions 
depend on the rates of production,  
  ( )        
 (    
        
    ),    (4.1) 
and survival,  
  (   )  {
  ∫   
  
   ̃                  ( ̃)   
  ∫ (  
    
   ( ̃))  ̃ 
 
       ( ̃)   
,   (4.2)   
of that constituent. The basal mass density,      
 , is the amount of constituent mass per 
unit area produced at each time step in normalcy; defined by calculating the constituent 
mass density fraction in normalcy divided by the mean age expectancy (according to the 
half-life) of that particular constituent. The gain-type parameters,   
  and    
  are unit-
less scalars that weigh the specific constituent‟s dependency on either the difference in 
current intramural stress from homeostatic (~100 kPa),     
(     )
  
, or similarly the 
difference in wall shear stress from its homeostatic value,    . Although, a decrease in 
    results in an increase in mass production, and vice versa. For example, it has been 
shown that a decrease in WSS causes acute ET-1 induced arterial constriction in attempt 
to restore the WSS target value [33, 74, 112]. Increases in ET-1 have been shown to, in 
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turn, cause increased production of collagen [50, 113, 114] and SMC [50, 115]. 
Intramural stress expected to increase 2 to 3 times in hypertension (Humphrey, 2002) 
while production rate,   ( ), is expected to increase 3 to 5 times. Hence, in this 
simulation we allow the gain-type parameters to vary between a reasonable range of 0.1 
to 10 [52].  
The first order kinetic removal function (equation 4.2) is dependent on fiber 
tension, where   ( ̃) symbolizes the difference between current tension at time  , and 
homeostatic tensions deposited at time   for  , either collagen or SMC. Elastin is 
assumed to neither be added nor removed since it is deposited during development and 
has a long half-life of 35 years [83, 116-118]. The rate-type parameter   
  accounts for 
constituent removal and is ~1/80 day
-1
 [92, 119]. Qualitatively, excess tension on a fiber 
leads to greater turnover due to increased MMP production and activity and therefore 
less constituent surviving from the time it was deposited,  , to the current time,   [120-
123]. It is important to note in a homeostatic state, where   ( ̃)    and   ( )  
      
  one can recover a constant apparent mass density, defined per unit area,  ( )  
  ( )        
 ∫   ∫   
  
   ̃  
 
     
  [42], where     
  represents the maximum age of 
the constituent. Therefore the CMM is good at predicting the salient features of 
hypertension. However, details of the intermediate molecules and their effect on cellular 
responses ultimately lead to these salient features are not accounted for in the current 
CMM.   
Consequently we have previously designed an ABM to account for cellular 
production of the primary intermediate vasoactive, growth, regulatory, and proteolytic 
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molecules that exist under normal conditions (Chapter III). Briefly, a virtual artery in the 
2D space domain is formed based off initial geometry and phenotype specifications. The 
artery consists of a single layer of endothelial cells and approximately 3 layers of SMCs. 
Each patch consists of a cell (or agent), matrix and biochemical factors and occupys an 
explicit 10 μm x 10 μm space. Each patch shares the physical space with the cell as well 
as other constituents (i.e. collagen and elastin). The total mass of SMCs at each time 
point, i, can be calculated as:  
    
            
                      (4.3) 
where,     
     is the current SMC mass of the vessel,    is the current vessel volume 
or total number of patches multiplied by the fixed volume per patch (1.0E-9 cm
3
/patch), 
ρ is the mixture density (1.05 g/cm3),   
     is the current collagen mass of the vessel, 
and       is the constant elastin mass of the mixture. Note that there is only one SMC 
per patch, but the mass and size of the SMC in the patch can evolve according to the 
mass of the other constituents occupying the patch. The average wall thickness of the 
vessel is calculated as, 
           √   ⁄    
          (4.4) 
where,    is the constant luminal radius (230 µm) and    is the current vessel area or 
number of patches multiplied by the area for each patch (1.0E-6 cm
2
/patch).  
 The behavior of each agent is determined by a selected set of 17 rules governed 
by 37 parameters. After a parameter sensitivity analysis, only 16 parameters caused the 
predicted amounts of SMC, collagen, PDGF, TGFb to diverge outside of the 95 % 
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confidence interval (Chapter III). Hence these parameters were rationally bound 
according to the sensitivity study.   
A strategy common in multi-scale biomechanical modeling is to let the lower 
scale models sequentially inform the higher scale models, which ultimately should lead 
to tissue- or organ-level behaviors of clinical importance. The tacit assumption in such a 
strategy is that the lower scale models, or associated data, are more reliable. Although it 
is true that experiments at lower scales are often better controlled (e.g., cell responses in 
vitro under well defined conditions versus responses of the same type of cell in vivo 
wherein many conditions are neither controlled nor known), the physiologic relevance of 
findings at the lower scale is often questionable. One must consider, therefore, all factors 
that contribute to overall model reliability. We suggest that although an advantage of 
multi-scale modeling is that one can integrate disparate models that exploit different 
types of data and predict different types of behaviors, there should be some areas of 
overlap when crossing each scale that enable congruency across scales to be evaluated 
and possibly improved. For example, because the ABM is based on cell-level data 
whereas the CMM is based on tissue-level data, one would not expect the two models 
initially to predict the same values of common outputs, as, for example, the production 
of particular molecules by the ABM (e.g., collagen) and the accumulation of mass 
associated such molecules by the CMM. We illustrate how differences in outputs that 
overlap (i.e. collagen and SMC mass) can actually allow iterative parameter refinements 
across scales, which should lead to increased congruency between models. Indeed, 
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because all data and models at each scale each possess inherent errors, enforcing 
congruency may lead to increased biological and physiological relevance. 
Previously, we have shown that the CMM and ABM paradigm can run in parallel 
to accurately predict clinically relevant arterial responses in homeostasis (Chapter III). 
This model was modified to include iterative internal congruency checks that allow a 
converged response to common metrics. That is, an objective function, 
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was used as the fitness function in a Genetic Algorithm (GA) heuristic to find optimal 
parameters that result in minimum error between the common metrics (i.e. collagen and 
SMC) of the CMM and ABM. Where C denotes mass of collagen either for the ABM or 
CMM present at each 6 hour time step j. Likewise M denotes the mass of smooth muscle 
predicted by either the ABM or by the CMM. The percent difference of these common 
metrics were calculated and averaged for both the normotensive (NT) and hypertensive 
(HT) simulation. A hypertensive simulation consists of a 30 % sustained pressure 
increase at day 2. The homeostatic simulation was over 224 time steps or 56 days (N) 
whereas the hypertensive simulation was over 2000 time steps or 500 days (S). The GA 
randomly generates 40 parameter sets (i.e. the population size) within the allowable 
values for each parameter. Each parameter set is run through the CMM and ABM and 
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the percent difference for each time step in one simulation were summed and divided by 
the total number of time steps to give the total fitness value (or error) for any given set of 
parameters. The next generation stochastically selects 40 new parameter sets based on 
the best fitness values from the previous generation. The process continues until 30 
generations have been completed. After error minimization, the best fit parameters were 
implemented into the CMM and ABM and their simulated results were plotted in the 
figure on page 59. 
 Based on results from parameter sensitivity studies conducted for the ABM 
(Chapter III) and CMM [42] parameters were either fixed or bound. Table 4.1 details the 
values for the fixed parameters. For the ABM, parameters making up the rules governing 
ECs production of PDGF and ET-1 based on shear rates were fixed. The rules governing 
gelatinases MMP-2 and MMP-9 removal of cleaved collagen and elastin were also fixed. 
For the CMM the homeostatic deposition prestretch, or the stretch at which new 
constituent material is laid down at are fixed. Collagen and muscle have greater 
deposition stretch because they turn over in a matter of days whereas elastin is produced 
almost entirely in the neonatal period. That is the change in length per unit of the 
original length of the fiber is less for collagen and muscle than elastin; since original 
length for elastin is when the artery is a lot smaller. The elastic parameters are used in 
the neo-Hookean strain energy equation used to model elastin and in the Fung 
exponential strain energy equations used to model collagen and passive smooth muscle. 
The muscle activation parameters define the circumferential stretch at which the active 
response of muscle is maximum and minimum; as well as and the constrictor to dilator 
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ratio and scaling parameter that effects the magnitude of the smooth muscle response to 
stretch. Lastly, the mass fractions for collagen, elastin and muscle in the abdominal aorta 
were initially set at 0.44, 0.28 and 0.28 respectively; and allowed to vary at t > 0. These 
constitutes are removed according to a first order kinetic equation that is a function of 
rate-type parameters of mass removal.  
For the ABM parameters bounds were chosen because the parameters were less 
known or the values resulted in imbalanced production and removal in homeostatsis (see 
Chapter III, methods and results) [Table 4.2].   
 
 
TABLE 4.1. Fixed parameter values used in the ABM and CMM to simulate a mouse 
abdominal aorta. These values were inferred from the literature and deemed either to be 
reliable or to be reasonable based on parameter sensitivity studies. 
 
Fixed Parameters 
ABM 
 Growth Factors 
                                             
                        
 Vasoactive Factors 
                                             
                       
 Removal Factors 
                                                    
                                            
                                                   
                                                            
CMM 
 Prestretches and Elastic Parameters 
   
         
          
      
               
               
              
        
      
 Muscle Activation Parameters 
                           
                   
               
 Initial Mass Fractions and Half-lives 
   ( )         ( )         ( )       
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TABLE 4.2. Parameter values and bounds used in the CMM (top 4 rows) and ABM 
(bottom 12 rows). See equations 4.1 to 4.2 and Table 3.1 for the associated equations or 
rules. 
 
Parameter Initial Value Lower Bound Upper Bound After Genetic 
Algorithm 
   
  1 0.1 10 0.15 
   
  10 0.1 10 0.44 
   
  1 0.1 10 6.16 
   
  10 0.1 10 8.18 
MMP-10 2.69E-04 2.69E-05 2.69E-03 2.50E-03 
MMP-1%A 0.39 0.039 3.93 0.28 
C0 0.009 0.0009 0.09 0.078 
CTGF 114.94 11.49 1149.42 865.90 
Mp -1.45E+09 -1.45E+10 -9.69E+08 -1.48E+09 
M0 80000 53333.33 120000 6.34E+04 
Ma1 71020 7102 106530 1.00E+04 
Ma2 100 66.66 1000 309.99 
       4.79E-07 3.19E-07 7.19E-07 5.37E-07 
PDGF0 4.17E-05 4.17E-06 6.25E-05 3.50E-05 
       1.65E-06 1.65E-07 1.65E+05 9.99E-06 
TGFβ0 1.03E-04 1.03E-05 1.03E-03 9.94E-04 
 
 
 
Results 
 Hypertension, defined herein as a sustained increase in blood pressure of 125.3 
mmHg (i.e. 30% of the in vivo MAP of mice) was simulated using the ABM and CMM. 
In response to hypertension, specifically the increased hoop stress calculated based on 
the law of laplace, causes increased SMC production of PDGF. Proliferation of SMCs is 
proportionally related to the increases in PDGF above baseline. Therefore the arterial 
wall thickens as a result of increased SMC mass. Figure 4.1 illustrates a mouse 
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abdominal aorta in normotensive conditions [Fig. 4.1 (A)] as well as after 500 days of 
elevated blood pressure [Fig. 4.1 (B)]. The endothelial layer is shown in yellow and the 
media in red. The inner radius and number of ECs is fixed. However this illustration 
shows the outward wall thickening.  
 
 
 
FIGURE 4.1. Graphical display of an ABM simulation of a mouse abdominal aorta (A) 
before and (B) after hypertension (defined herein as a sustained 30% increase in mean 
pressure).  
 
 
 
Figures 4.2 - 4.4 illustrate the predicted arterial response by the ABM (shown in 
blue) and CMM (shown in black) to the sustained increase in pressure [Fig. 4.2 (A)] 
using the initial parameters as determined from the literature. For the CMM, the increase 
in pressure leads to passive increase in the internal radius [Fig. 4.3 (A)]. This causes 
increased wall stress, over the basal value, [Fig. 4.2 (B)] in addition to decrease shear 
stress [Fig. 4.2 (C)]. The stress is sensed by the constituent‟s results in mass 
accumulation [Fig. 4.3 (D, C)] and wall thickening [Fig. 4.3 (B)].  
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FIGURE 4.2. CMM and ABM predictions of (A) load and (B, C) stresses, normalized 
with respect to the homeostatic values, before parameter refinement via the genetic 
algorithm. Note that the pressure was prescribed in the CMM whereas the shear stress 
(actually inner radius) was prescribed in the ABM. The trends were similar for the 
evolution of hoop stress due, in part, to the initial effort of parameter selection (see 
Table 4.2). 
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FIGURE 4.3. (A) Wall caliber, (B) thickness, and (C-E) constituent compositions for 
the case of a 30% increase in mean luminal pressure before parameter refinement. (E) 
Elastin is constant in the CMM and currently not predicted by the ABM. 
 
 
 
 The ABM behaves similarly to the CMM in that the increase in loads 
experienced by the cells leads to mass production and accumulation. In addition, the 
target thickness value of ~30% is reached for a 30 % increase in pressure. In the ABM 
the geometry is determined by number of cells, each containing a fixed size. Therefore, 
the increase in SMC number is going to have a direct correlation to the total thickness 
[Fig. 4.3 (B, C)]. Collagen, produced by the ABM, is contained within the same “patch” 
that a SMC occupies. In response to the increased stress smooth muscle cells produce 
TGF. When TGF is present, the rate of collagen production increases [Fig. 4.3 (D), Fig. 
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4.4 (B)]. The increase in collagen (as a function of TGF) is followed by collagen 
removal (as a function of MMP-1). Thus, when collagen amounts appear to plateau [Fig. 
4.3 (D)] around day 220 so does the TGF and MMP-1 [Fig. 4.4 (B, C)]. Note that the 
concentrations of soluble factors are a product of the entire arterial volume at any given 
time step, hence the total mass of any particular constituent increases as the total mass of 
the arterial wall increases.  
 
 
 
FIGURE 4.4. ABM predictions of changes in soluble constituents due to a 30% increase 
in mean pressure.    
 
 
 
 Reparameterization of the bounded parameters shown in Table 4.2 was achieved 
using a genetic algorithm to minimize the percent difference, at each time step, of 2 
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common outputs, collagen and SMC mass. The mean percent difference between the 
common outputs was 5.1%. The parameter set chosen is documented in the right-most 
column of Table 4.2. The results after implementation of these parameters are shown in 
Figure 4.5. As seen before, a 30% step increase in pressure (fixed by the CMM, 
calculated by the ABM) [Fig. 4.5 (A)] immediately causes the hoop stress to increase 
34% and wall shear to decrease due to passive distention and wall thinning of the artery 
[Fig. 4.5 (B-E, CMM)]. Now, both models predict the characteristic arterial 
observations due to hypertension (i.e. proportional wall thickening to the increase in 
pressure, elevated SMC and collagen mass, nearly constant inner radius and wall shear 
stress, and recovery of the target circumferential stress). Moreover, both the ABM and 
CMM were able to modify their parameters to allow for consistency across the common 
metrics SMC and collagen mass [Fig. 4.5 (F, G)] as desired. Remarkably the wall 
thickness, based off structurally significant constituents in the CMM and number of 
patches in the ABM, were also very similar [Fig. 4.5 (E)]. In addition, the ABM predicts 
a rapid increase in growth factors, metalloproteinase‟s, and gelatin mass. Note the 
sustained increase in mass corresponds to the sustained increase in wall thickness after 
the artery appears to have remodeling in a new basal state ~120 days. 
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FIGURE 4.5. Illustrative results after implementation of the parameters (see Table 4.2) 
determined through error minimization using the genetic algorithm.  
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Discussion 
Hypertension was chosen as a disease to model due to the relatively consistent 
geometrical and mechanical observations over time. These findings can be used to verify 
if the predictions after parameter refinement are correct. When building a theoretical 
model intended to be applied to predict changes of complex diseases, it is important to 
first establish model parameters that lead to great predictions in the known case.  
Numerous reports indicate that, despite even modest alterations in arterial 
hemodynamics, significant structural and mechanical changes may occur in attempts to 
restore circumferential wall stress to its target value. In Goldblatt hypertensive Wistar 
rats, the circumferential stress did not return to normal until 126 days [97]. Likewise, 
Wolinsky shows in a series of Goldblatt hypertension studies in rats that wall stress is 
significantly greater than control at 70 days, but returns to normal by 140 days [124]. 
The ABM alone, governed primarily by experimental data from cell experiments, 
predicted a delayed remodeling response wherein hoop stress did not return to within 1% 
of its target value until day 350. In contrast, the CMM, which is governed primarily by 
data from tissue-level turnover rates plus stored energy functions for normal structurally 
significant constituents, predicted a faster remodeling response, returning hoop stress to 
within 1% of its target value by day 70. After reparameterization, both models recovered 
within 1% of the target hoop stress value by day 125 [Fig. 4.5 (B)], which is closer to 
that seen experimentally.   
In this hypertension simulation, the aortic wall thickened while maintaining 
nearly constant the inner radius. This result is consistent with previous hypertensive 
 61 
animal studies looking at the aorta of rats [49, 97, 125-128]. This thickening is likely due 
to a combination of an imbalanced relationship in both smooth muscle and matrix 
turnover, that is, increased SMC replication and synthesis leading to increased medial 
thickness without a counteracting increase in apoptosis or MMPs [129]. Using an aortic 
coarctation model in rats, Olivetti et al. (1980) [130] and Liu and Fung (1989) [131] 
observed a 39% increase in wall thickness of the proximal aorta after 8 days. Herein, if 
we model a similar 50% increase in pressure, the ABM and CMM predict a 2.8% and 
8.3% increase, respectively, by day 8. These predictions are much lower than the 
experimental ones. However, more experimental data needs to be collected in order to 
deem these predictions inaccurate (see Chapter V). 
Hypertension causes increased SMC content. Hu et al. (2008) [132] quantified 
relative SMC content in the aorta of a hypertensive mini-pig model and similarly found a 
gradual increase up to 13% by 56 days. The ABM predicts an 8.22% increase in relative 
SMC content (i.e. SMC mass/mixture mass) from baseline by 56 days; the CMM 
predicted a 9.25% increase [Fig. 4.3 (C)]. Using the parameters obtained from the 
genetic algorithm both models predict about a 13.6% increase in relative SMC from its 
baseline value (i.e. 28% of the mixture) [Fig. 4.5 (F)]. Therefore, reparameterizing the 
model brought the predictions closer to the experimental result.   
Albeit for the basilar artery, Hu et al. (2007) [96] report a gradual increase in 
medial collagen from 24.2% (control) to 31.5% by 8 weeks of aortic coarctation induced 
hypertension in mini-pigs. The ABM and CMM predict an increase in collagen as well 
although the increase is much less than 30% by 8 weeks. At 8 weeks the relative 
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collagen mass is only about 3.7% above baseline [Fig. 4.5 (G)]. This may be due to 
differences in artery type/animal type or because Hu et al. (2007) [96] only measured 
collagen in the media. In contrast to our predictions that collagen increases and then 
plateaus, others have shown a rapid increase in collagen, peaking at 4 weeks, followed 
by a decline toward normal by 8 weeks in coarctation models of rabbit and pigs and a 
Goldblatt model in rats [49, 124]. Albeit not shown herein, depending on the parameters 
chosen, the CMM and ABM can also predict collagen mass that is not monotonic over 
time illustrating the versatility of this modeling approach.  
Elastin synthesized in arteries during the perinatal period normally remains for 
much of the lifespan of the animal. Loss of elastin in normal aging results from 
structural fatigue and degradation [83, 117, 118]. In our simulations, we allowed a 
constant mechanical contribution of elastin, that is, no degradation or production. A 
constant mass of elastin does not imply a constant mass fraction, however. Increased 
accumulation of collagen and smooth muscle decrease the mass fraction of elastin, 
which has been reported to result from hypertension in pigs over just an 8 week period 
[132] and in rats from 10 to 20 weeks despite a later (at 70 weeks) return toward normal 
[49, 124].    
To our knowledge, this work presents the first application of an agent based 
model of arterial wall remodeling in response to hypertension. Biochemical stimulation 
modulates growth rates, migration, protein expression, and phenotypic morphology of 
cells. Mechanical stimulation in turn effects the biochemical expression and vice versa.  
For example, exogenous TGF-β protein augmented wall thickening, likely due to 
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collagen deposition, in in vivo injured arterial wall models [133-135]. Likewise, a TGF-
β antagonist suppressed intimal thickening and collagen deposition in other models [136, 
137]. The multiscale model presented here captures these mechanobiological 
relationships. In addition, TGF- β1 and -3 have been shown to be upregulated by day 1 
after sudden onset of hypertension created by a coarctation of the mid-thoracic aorta in 
rats [128]. Therefore, consistent with our model predictions, TGF-β concentration 
rapidly increases then drops towards normal by the fourth week following the initiation 
of hypertension [128].   
Limitations associated with data found in the literature include the modest range 
of shear stress and/ or circumferential stress to which the cells are exposed. The standard 
physiological range is 0.7 to 1.5 Pa for wall shear stress (WSS) and 100 kPa for 
circumferential stress (σθ). Yet, the mean WSS depends on the animal and type, location, 
and size of the vessel of interest. For example, the mean WSS in the infrarenal aorta of 
mice is significantly greater than in humans (8.8 compared to 0.48 Pa, respectively).  
The average diameter along the aorta for the mouse and human is about 0.07 and 1.3 cm, 
respectively. Therefore, exposing cultured cells to a presumed standard physiological 
range of WSS may not be appropriate. In addition, testing and acquiring too few data 
points for a mechanical dose response curve is not a good representation of the complete 
response. As more literature finding become available, in particular with respect to half-
lives and removal rates of soluble factors, the ABM can readily integrate these findings. 
In conclusion, we presented in the last 2 chapters an ABM and CMM each with 
their own advantages and disadvantages. The ABM has an advantage in that it directly 
 64 
accounts for literary findings describing cell behavior, and stochastic variability in the 
apoptosis and proliferation rates. An advantage of the CMM is that it accounts for the 
specific strain-energy density relationships of the structurally significant-constituents in 
the artery. In addition, the mass production and removal of these constituents is based on 
shear stress, Cauchy stress, constrictor/dilator concentration, half-life and tension. A 
disadvantage of the ABM is that it lacks a strong mechanical framework. Whereas a 
disadvantage of the CMM is it assumes axisymmetry and doesn‟t account for specific 
biological responses. Therefore, the natural model evolution would be to couple the 
ABM and CMM in order to create a multi-scale model. That is one could use the ABM 
to calculate biochemical molecules that would then be implemented into the mass 
production and removal functions in the CMM at each time step. The CMM in turn 
could calculate stress, loads and geometry that would be feed into the ABM. This cycle 
would continue until the desired time or stable condition is reached. In the future it is 
conceivable constitutive equations in the CMM, which depend on the ABM, can be 
implemented into finite element modeling to simulate a more accurate 3-dimensional 
artery. 
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CHAPTER V 
HYPERTENSION – EXPERIMENTAL FINDINGS 
Overview 
Hypertension often manifests primarily as a thickened arterial media and, to a 
lesser degree, thickened intima and adventitia. Less is known, however, regarding the 
evolution of such changes in different arteries and the different underlying structural 
changes. Herein, we use a porcine coarctation model of hypertension in attempt to 
elucidate structural changes temporally and spatially in three different arterial beds. 
Firstly, we quantify the number of cells per wall area to determine whether the increase 
in mass is due primarily to hypertrophy or hyperplasia. Also, by determining the area 
fraction per wall of smooth muscle actin, the main protein component making up the 
contractile apparatus of cells, we will further help to characterize the overall vasoactive 
capacity. Through quantification of collagen fibers we can infer their contribution to 
overall wall stiffening. Finally, possible involvement of circulating systemic cells is 
addressed by identifying hematopoietic cells and macrophages, the latter of which may 
contribute to matrix turnover via the production of proteinases.  
Introduction 
 Hypertension, defined as a persistent elevation of blood pressure, affects over 50 
million Americans and is a significant risk factor for many diseases, including 
abdominal aortic aneurysms, aortic dissections, atherosclerosis, cerebral vasospasm, end 
stage renal failure, heart failure, intracranial aneurysms, stroke, and so forth. 
Hypertension is caused by and causes significant remodeling of arteries and arterioles, 
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which includes phenotypic changes of vascular cells and associated changes in 
extracellular matrix, often leading to an overall increased stiffness of the vessel. Indeed, 
mounting evidence suggests further that stiffening of central arteries (i.e., aorta and 
carotids) may be both an initiator and an early indicator of subsequent cardiovascular 
risk, particularly for low resistance organs such as the heart, brain, and kidneys [138-
142]. The ratio of collagen to elastin normally increases with distance from the heart, but 
this ratio can be exaggerated in hypertension. Because mature fibrillar collagen is stiffer 
than elastin, primarily resisting arterial distension at high systolic blood pressures, an 
increase in collagen can also contribute to increased arterial stiffness [143-145]. The 
goal of this work, therefore, was to contrast progressive histological changes in the 
proximal aorta as well as coronary and cerebral arteries to elucidate possible differences 
in the type, extent, and time course of arterial remodeling in an established mechanically 
induced animal model of hypertension. 
Methods 
Animal Model. All animal protocols were approved by the Institutional Animal 
Care and Use Committee at Texas A&M University. Arterial specimens were excised 
from adult mini-pigs before or at prescribed time-points following the surgical creation of 
a supra-diaphragmatic aortic coarctation that induced hypertensive conditions in the 
vessels of interest (see [17]). Briefly, a balloon-inflatable silicone occluder (In vivo 
Metrics, Inc; reinforced by Soloman Scientific), prefilled with a 50% dextrose solution, 
was placed over a Gore-Tex patch that was wrapped around the supra-diaphragmatic 
aorta, between intercostal vessels, and secured with suture. The occluder was connected 
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via stiff tubing to a vascular access port placed subcutaneously in the neck, which 
allowed it to be inflated or deflated within the conscious animal based directly on desired 
changes in blood pressure that were measured via an indwelling transducer placed within 
either the internal thoracic artery or the right carotid artery. Arterial pressure and heart 
rate were recorded for 30 seconds every 2 hours throughout the study.  
Beginning approximately 1 week after surgery, the aorta was coarcted gradually 
by adding small amounts of dextrose to the occluder over a 7 to 10 day period until the 
daily average mean arterial pressure (MAP) reached or exceeded 150 mmHg. Data were 
collected from 41 mature (7 to 16 month old) male mini-pigs (Sinclair Research Center, 
Inc, Columbia, Mo): 16 normotensive (NT) controls and 25 hypertensive (HT) animals 
[Table 5.1]. Specifically, arteries were harvested from true controls (n = 2), from surgery 
controls (n = 3) without an occluder, from NT animals at 2 (n = 2), 4 (n = 4), 6 (n = 3), 
and 8 (n = 2) weeks following a sham surgery wherein an occluder was implanted but not 
inflated, and from HT animals at 2 (n = 7), 4 (n = 7), 6 (n = 5), and 8 (n = 6) weeks after 
the animal reached its target mean arterial pressure (>150 mmHg). Notwithstanding 
increases in pressure over time during hypertension (Table 5.1), the overall averaged 
MAPs were 131  6 mmHg in NT and 168  17 mmHg in HT animals, which were 
significantly different (one-way ANOVA, p < 0.001); the overall averaged pulse 
pressures were 37  6 mmHg in NT and 53  10 mmHg in HT animals, which were also 
significantly different (one-way ANOVA, p < 0.001).  
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TABLE 5.1. Averaged number, mean arterial pressure, and pulse pressure of pigs at each 
time step after induced hypertension.  
 
Condition Number of Pigs 
MAP Averaged over 
the last 2 wks 
(mmHg) 
Pulse Pressure 
Averaged over the 
last 2 wks (mmHg) 
NT 16 131  6 37  6 
2 wk HT 7 152  6 48  6 
4 wk HT 7 171  11 56  12 
6 wk HT 5 171  14 55  5 
8 wk HT 6 181  20 55  12 
Note: NT denotes normotensive and HT denotes hypertensive. MAP is mean arterial 
pressure.  
 
 
 
Histology and Immunohistochemistry. Immediately following exsanguination, 
segments of descending thoracic aorta 3+ cm proximal to the occluder (P-Ao) as well as 
segments of the left anterior descending (LAD) coronary artery and the middle cerebral 
artery (MCA) were dissected free of perivascular tissue and fixed at unloaded conditions 
by immersion in fresh 4% paraformaldehyde for one hour. Specimens were then 
embedded in paraffin, sectioned at 5 µm, photobleached, deparaffinized, rehydrated, and 
stained for either standard histology or immunohistochemistry. Prior to immunostaining, 
slides were further placed in a local greenhouse for 5 days to reduce auto-fluorescence of 
endogenous fluorophores, primarily from elastin and collagen (see [146, 147] for details). 
Sections were stained with Verhoeff-van Gieson (VVG) for elastin (Verhoeff) and 
collagen (van Gieson), and with antibodies against alpha smooth muscle actin (αSMA) 
for contractile cells, von Willebrand factor (vWF) for endothelial cells of the cerebral 
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arteries, MAC387 for leukocytes, and CD34 for hematopoietic progenitor stem cells. 
Antibodies and the determined optimal dilutions are detailed in Table 5.2.  
 
 
TABLE 5.2. Primary, secondary, and tertiary antibodies and treatment specifications for 
immunostaining of porcine arteries.  
 
Primary Vendor Concentration Secondary Vendor Concentration Tertiary Vendor Concentration 
(clonality) (code) and Time  (code) and Time  (code) and Time 
aSMA Abcam 2 µg/ml; Alexa 594 Invitrogen 4 µg/ml;    
(P) (ab5694) RT 60 min   (A11012)  RT 60 min    
L1 protein Abcam 20 µg/ml; Alexa 488 Invitrogen 10 µg/ml; Alexa 488 Invitrogen 10 µg/ml; 
(M: MAC387) (ab22506) 4 °C overnight   (A11054) RT 60 min  (A11054) RT 60 min 
CD34 Abcam 2 µg/ml; Alexa 594 Invitrogen 4 µg/ml; Alexa 594 Invitrogen 4 µg/ml; 
(M: MEC 14.7) (ab8158) 4 °C overnight  (A21211)  RT 60 min  (A11012) RT 60 min 
vWF Abcam 80 µg/ml; Alexa 594 Invitrogen 4 µg/ml;    
(P) (ab6994) RT 60 min  (A11012)  RT 60 min    
 
Note: P denotes polyclonal, M denotes monoclonal, Alexa denotes Alexa Fluor® 
 
 
Indirect immunofluorescent staining was performed following the Abcam double 
immunofluorescence protocol with slight modifications [148]. Optimal antigen retrieval 
method was found to be heat-induced epitope retrieval (using a pressure cooker) for 3 
minutes with sodium citrate retrieval buffer at pH 6 for all antibodies. Sections with 
intracellular target protein sites (i.e., αSMA, SM-MHC, vWF, and MAC387) were 
permeabilized with 0.25% Triton X-100 in PBS for 10 minutes. Subsequently, slides 
were incubated in 10% goat serum for 30 minutes to prevent non-specific binding of 
antibodies. Slides were incubated with the primary antibody, washed 3x for 5 minutes in 
PBS, and incubated with their fluorescent secondary antibodies (see Table 5.2). Slides 
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were then either incubated for 30 minutes with fluorescent tertiary antibodies for greater 
fluorescence, as in the case of the low-abundance target proteins MAC387 and CD34, or 
washed 3x for 5 minutes in PBS and counter-stained with premixed DAPI mounting 
medium (ProLong® Gold antifade reagent with DAPI, Invitrogen (P-36931)). After 
tertiary incubation for MAC387 and CD34, the sections were mounted with the premixed 
DAPI medium and cover-slipped for imaging. All experiments were preformed with a 
negative control (i.e., primary antibody substitution with PBS) to determine background 
fluorescence. A negative isotype control (rabbit IgG, Vector Laboratories (I-1000)) was 
also used to confirm specific staining.  
Image Acquisition and Quantification. Arterial samples were imaged using an 
Olympus BX/51 fluorescence microscope coupled with an Olympus DP70 digital 
camera. This microscope is equipped with diascopic (transmitted) and episcopic 
(reflective) optical pathways to capture bright-field and dark-field images; it is also 
customized for circularly polarized illumination [9] to capture polarized light images. 
Köhler illumination was established and settings for microscopic illumination, exposure 
times, and color balance of the digital camera were maintained for each set of slides to 
enable subsequent comparisons. For dark-field images, settings were found by zeroing 
out the fluorescence of the same artery-type negative control (i.e. processed exactly the 
same except without the primary antibody) for each batch of staining.  
For quantitative morphological analysis, an appropriate objective was used to 
acquire an image of the entire artery (i.e., dissection microscope for P-Ao, 20X for LAD, 
and 40X for MCA) and at least two representative color images of the arterial wall (i.e., 
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4X for P-Ao, 4X for LAD, and 20X for MCA) per specimen. In some cases, images were 
acquired at a higher magnification for better visualization. Image files were saved in 
tagged-image file format (TIFF). GIMPshop 2.2.8 was used to overlay fluorescent images 
taken with different filters (i.e. Fitc, Tritc, PI).  
A “detail analysis” method was used to determine, for each type of artery, the 
following: (1) inner and outer radius (using the circle and hydraulic diameter formulae), 
(2) mean wall thickness, (3) mean thickness of intima, media and adventitia, (4) area 
fraction of positive SMA stain in the wall, (5) area fraction of collagen in the wall, (6) 
area fraction of elastin in the wall, (7) nuclei count per wall area, (8) number of 
hematopoietic cells, (9) number of macrophages, and (10) endothelial cells in the cerebral 
arteries. 
To quantify mean inner and outer radius as well as wall thickness for 3 different 
types of arteries in all 41 pigs we stained the arteries with either VVG or PSR and 
captured an image of the whole arterial ring. The outer diameter of the P-Ao was larger 
than 7 mm, therefore a dissection microscope was used to capture the whole artery. In 
addition, the peri-vascular tissue was removed from the P-Ao before staining. For the 
LAD and MCA arteries, we manually cropped the myocardium and connective tissue 
from the adventitia using ImageJ and GIMPshop. The luminal boarder was detected using 
magic wand in GIMPshop, and the lumen was filled black for better image recognition. 
An image analysis program was written in MATLAB 7.9.0 (R2009b) to calculate the 
luminal and wall area as well as the luminal and outer adventitial perimeter [Fig. 5.1]. 
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The area of a circle and circumference as well as hydraulic diameter formulae were used 
to calculate radius and thickness for each vessel.  
 
 
 
FIGURE 5.1. The first row shows original images of the proximal aorta (P-Ao), left 
anterior descending artery (LAD), and middle cerebral artery (MCA). The LAD and 
MCA were cropped of connective tissue. A custom computer algorithm was then used to 
identify the region of interest and delineate the inner and outer boundaries.  
 
 
 
 To verify the thickness calculations, another image was taken at greater 
magnification of just the arterial wall. The connective tissue was cropped from the 
adventitia in the cases of the LAD and MCA. To obtain layer thickness, the intima and/or 
media were cropped separately [Fig. 5.2]. The region of interest was found using a color 
threshold module and refined using a median filter (to remove small particles). The mean 
thickness was then calculated by dividing the total area (pixels
2
) by the image width 
(pixels) and then using the scale bar to convert to metric units. That is, for an image with 
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dimensions m x n, where m is the width and n is the height, the mean thickness is defined 
as           ∑   
     
    ⁄ , where,   
    is the thickness of the wall at each pixel (i) 
along the width. For the LAD and MCA, medial thickness was determined by subtracting 
the adventitia. Similarly, the intimal thickness was found by subtracting the media and 
adventitia from the total. 
 
 
 
FIGURE 5.2. Mean wall thickness for each layer (i.e., intima, media and adventitia) was 
found based off the cropped images delineating the separation for each layer. This was 
done for all artery types (P-Ao, LAD, MCA) under all conditions (surgery controls, 
normotensive controls, 2 wk, 4 wk, 6 wk, and 8 wk hypertensive).  
 
 
 
 To get the area fraction of positive fluorescence we first cropped the lumen and 
connective tissue, then filled the wall with white for easy recognition. Then we 
 74 
converted the image into a grayscale images for each channel (red, green, blue), with 
pixel values ranging from 0-255 depending on the intensity of a specific color [Fig. 5.4]. 
First we determined the proper threshold value          to convert the red, green or 
blue channel images into a binary image. To do this, we subtracted the total color-
specific intensities in the arterial wall from the color-specific intensities in negative 
control images [Fig. 5.3]. The threshold cut-off was set to be the minimum value for the 
last bin in the resulting mode [Fig. 5.3 (C)]. This was done for each set of images as a 
batch process (divided based on the microscope objected used and the stain), thereby 
ensuring specific positive staining with minimal background or observer bias. The total 
pixels identified according to the stain were then divided by the total pixels making up 
the artery wall to give us the area fraction of positive stain in the wall section. 
 
 
FIGURE 5.3. For each fluorescently stained set of images, the proper threshold was 
determined. This was done by using batch processing to get the normalized average 
density for all images taken by a certain objective, for a certain stain and a certain artery 
type (e.g. 10x objective, SMA stained, LAD arteries). The resulting bar plot (A) was 
then subtracted from a bar plot of the negative control images (B) to give a bar plot of 
the true stain intensity range (C). Therefore the threshold to convert an image to a binary 
image was determined (dashed line in (C)). The abscissa was normalized out of 255.  
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FIGURE 5.4. (A, B, C) After manual cropping, each image was converted to a grayscale 
image according to the desired color channel (i.e., blue for nuclei, green for elastin, or red 
for SMA). (D, E, F) A predetermined threshold value [see Fig. 5.3] was used to convert 
the gray scale image to a binary (i.e., black and white) image. Shown here is a 2 week 
hypertensive LAD. 
 
 
 
 Autofluorescence was not an accurate measure for elastin in all cases. This is due 
to the fact that we placed the samples in a greenhouse for 5 days to reduce the 
autofluorescence. In addition, for the large aortic samples we had to use a 4x objective 
and thus lost a lot of the autofluorescent signal. Therefore, a custom routine was created 
in MATLAB (R2009b) that would analyze the samples stained for elastin using VVG. 
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The VVG stain also stains nuclei in some cases [Fig. 5.5]. Therefore, the program was 
created to have an adaptable threshold designating the minimum size a blob has to be.  
 
 
 
FIGURE 5.5. Algorithm created to determine the area fraction of elastin in the wall. First 
a threshold was used to determine the “black” elastin. Second a threshold was added to 
remove the black nuclei blobs. Then the ratio of elastin pixels to wall pixels (non-blue 
portion) was determined. 
 
 
 
The area fraction of total fibrillar collagen in the arterial wall was quantified 
similarly from Picro-sirius red birefringent images.  Briefly, a brightfield image was used 
to determine the region of interest and a darkfield image to determine the collagen 
(birefringence), with anything not black by a threshold level considered to be collagen. 
The collagen area (in pixels) was then divided by the total wall area (in pixels) to get the 
ratio of collagen in the wall.  
Finally, the total number of cells was determined by a custom program for nuclei 
written in MATLAB, Version 7.9.0.259 (R2009b) [Fig. 5.6 (A)]. The centroid of each 
nucleus was identified according to minimum size, separation, and intensity [Fig. 5.6 
(B)]. In addition, the inner and outer boundaries were found based on orientation and 
color threshold (since the extravascular areas were cropped to white). The number of 
 77 
nuclei relative to wall position, with 0 being the luminal boundary and 1 being the 
adventitial boundary, was then plotted [Fig. 5.6 (C)].  The smaller number of 
hematopoietic and macrophages were manually counted and scored.  
 
 
 
FIGURE 5.6. (A) Each arterial wall section was cropped of extravascular areas (white), 
the inner and outer boarders were determined, and the centroid of nuclei was identified 
(green astric). (B) Zoomed in section of the wall shows good nuclei detection. (C) The 
number of nuclei as a function of wall position (where 0 is the lumen and 1 is the outer 
adventitia boarder) was determined for each image.  
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Results 
 Sustained mean arterial pressure above 150 mmHg led to significant alterations 
in the arterial geometry of the P-Ao, LAD and MCA. The inner radius of the P-Ao and 
MCA arteries did not significantly increase or decrease after 2, 4, 6, or 8 weeks of 
hypertension [Fig. 5.7 (A, C)]. However, the LAD increased in caliber 50%, 51%, 17% 
and 61% at weeks 2, 4, 6 and 8, respectively, compared to the normotensive controls. In 
addition, significant wall thickening was observed in the LAD and P-Ao after increased 
mean pressure for 2, 4, 6, and weeks [Fig. 5.8]. The mean aortic wall thickness, as 
calculated based on the measured area of the entire ring, significantly increased by 56% 
compared to the normotensive controls after only 2 weeks. The wall was 64% thicker 
after 8 weeks. Due to the size of the P-Ao (over 12 mm in outer diameter) a dissection 
microscope was used to capture the entire cross-section. Because details may have been 
lost in doing so, at least 2 images of the aortic wall were taken at higher magnification. 
The mean wall thickness, as measured from the wall segment at higher resolution, still 
shows a significant increase at week 2 (40%) from baseline, and 61% by week 8. The 
increase in thickness was even more drastic in the LAD. The measured mean wall 
thickness increased 220% fold by the second week. The LAD continued to increase in 
mass as observed in the week 4 results (250%). However, at week 6, the wall thickness 
decreased to 80% increase over the normal value, but increased again by week 8 to 
242% over normal. The same trend, but slightly less drastic, was also observed using the 
thickness value calculated from the images viewing the entire artery. Moreover, the 
inner radius of the LAD followed this pattern [Fig. 5.7 (B)]. The MCA did not 
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significantly increase or decrease in wall thickness at any time during hypertension [Fig. 
5.8 (C)].   
Mean thickness distributions for each layer (i.e. adventitia, media, and intima) 
were quantified for each artery type and condition. Thickening of the P-Ao was 
attributable almost entirely to the media and intimal layers [Fig. 5.9 (A)]. In contrast, the 
LAD thickened most in the adventitial layer, exhibiting a 3-fold increase in thickness 
after only 2 weeks [Fig. 5.9 (B)]. By 4 weeks, the medial and intimal layers had 
increased in thickness 2.2- and 2.5-fold respectively; the adventitial layer was still 2.5-
fold thicker than the normotensive controls [Fig. 5.9 (B)]. Although the overall wall 
thickness of MCAs did not change, the distribution of mass shifted from the intima to 
the media while the adventitia remained nearly the same. Figure 5.9 (C) shows that the 
intima went from 30-micrometers to 5-micrometers after 8 weeks. Conversely, the media 
increased from a thickness of 53-micrometers to 86-micrometers after 8 weeks.   
Despite significant changes in wall thickness in the P-Ao and LAD, cell density 
(i.e. cells per square micrometer) remained fairly constant. Figure 5.10 illustrates the 
cell density for each artery type over the 8 week hypertensive period. Note, however, the  
 
 
 
 
 
 80 
density of cells in the wall is different depending on the artery type. For example, the 
starting densities were 0.000127, 0.00378, and 0.005497 cells/µm2 for the P-Ao, LAD 
and MCA respectively. Note this order is inversely parallel to the amount of elastin in 
these arteries. An unknown but statistically significant 15% decrease in cell density is 
observed at week 6 in the MCA, which is recovered by week 8.   
The number of nuclei as a function of radial position from the lumen to the outer 
adventitial border was quantified. Strikingly the P-Ao and LAD maintained similar 
trends throughout the G&R time course [Fig. 5.11 (A, B)]. Although the MCA changed 
the least, in regards to geometry, cell phenotypic changes, and matrix 
production/removal, the proportion of nuclei with respect to position and time shifts the 
most [Fig. 5.11 (C)]. Similar to all artery types, the density was highest in arterial tissue 
within 10% of the lumen. In the P-Ao the cell count maintained fairly constant until the 
outer fourth of the vessel (presumably the adventitia) [Fig. 5.11 (A)]. For the LAD and 
MCA, the cell count tends to gradually decrease antegrade from the lumen [Fig. 5.11 (B, 
C].  
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FIGURE 5.7. Inner radius of control (week 0) and hypertensive arteries (weeks 2, 4, 6, 
and 8) Mean ± SEM. The inner radius was calculated using the circle formula based on 
the wall area calculated from images showing the entire artery. * p < 0.05, unequal two 
sample t-test 
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FIGURE 5.8. Mean wall thickness from the P-Ao [A], LAD [B], and MCA [C] after 
sustained hypertensive conditions for 0, 2, 4, 6, and 8 weeks Mean ± SEM. Wall 
thickness was calculated using,   √     ⁄  √   ⁄ , where A = area, v = vessel and 
l = lumen, from whole arterial rings as well as measured from higher resolution images 
of a section of the wall. [A, B] The P-Ao and LAD significantly increased in wall 
thickness compared to the control. [C] The MCA did not show any statistically 
significant change in thickness over the 8 weeks. * p < 0.05, unequal two sample t-test 
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FIGURE 5.9. Mean thickness distribution of the adventitia, media and intima in the (A) 
P-Ao, (B) LAD and (C) MCA Mean ± SEM. (A) The P-Ao significantly thickens in the 
adventitia, media and intima. (B) The LAD significantly thickens in both the media and 
adventitia after 2 weeks. (C) The distribution of mass is shifted to the media in the 
MCA, although only significantly at week 4 and 6.  * p < 0.05, unequal two sample t-test   
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FIGURE 5.10. (A, B, C) Cell density of the wall of the P-Ao, LAD and MCA as a 
function of time Mean ± SEM. (C) The cell density decreases slightly, but significantly 
in the MCA at week 6, and is recovered by week 8. * p < 0.05, unequal two sample t-test 
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FIGURE 5.11. Normalized number of nuclei as a function through the arterial wall for 
each artery type ((A) P-Ao, (B) LAD, (C) MCA) at each experimental time point (NT 
control, and 2, 4, 6 and 8 week HT).    
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PSR birefringent staining was used to identify and quantify fibrillar collagen 
content in the arterial wall. The basal value of collagen in the P-Ao constitutes about 
9.5% of the arterial wall [Fig. 5.12 (A)]. At 2 weeks of hypertension, collagen was not 
significantly different. However, at 4 weeks collagen significantly increased in the P-Ao 
by 2.9-fold. Although, slightly decreased at 6 weeks, at 8 weeks collagen in the P-Ao 
was 3.3-fold higher than the basal value. Unlike the P-Ao, collagen did not significantly 
increase or decrease over the 8 week period in the LAD or MCA [Fig. 5.12 (B, C)]. 
Smooth muscle actin (SMA) is typically used as a marker of smooth muscle 
cells, particularly those exhibiting a contractile or vasoactive phenotype. Two weeks 
after hypertension was induced in the pigs, the percent of SMA decreased significantly 
by 31% in the P-Ao [Fig. 5.13 (A)], after which overall cell contractility slowly 
increased; by week 8 there was 6% more SMA than in the normotensive arteries (albeit 
not statistically significant). This pattern was also seen in the MCA [Fig. 5.13 (C)], 
except that SMA decreased initially by 20% and did not start increasing again until week 
6. At 2 weeks, the LAD exhibited the opposite effect [Fig. 5.13 (B)]: there was an 
increase overall wall contractility. From 4 to 8 weeks the percent of SMA in the LAD 
leveled off at 41%.  
Under healthy conditions, arterial elastin is thought to be minimally produced or 
removed past the neonatal period [83, 116-118]. Herein, the environmental conditions 
are altered for up to 8 weeks and the relative content of arterial elastin does not stay the 
same in all arteries. The P-Ao, a naturally elastic artery, shows a gradual yet 
insignificant increase in elastin after the second week. At week 8 the elastin percent in 
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the wall is significantly higher than the control by 43% [Fig. 5.14 (A)]. Elastin did not 
significantly change in the LAD except at week 4. At week 4, elastin content in the LAD 
wall was 67.9% greater than the control; elastin was increased primarily in the media in 
concentric layers. In a normal healthy LAD elastin is typically not present in the medial 
layer. In the MCA elastin did not significantly increase or decrease. In both the LAD and 
MCA the IEL became straighter.   
In addition to matrix alteration and phenotypic changes, circulating blood cells 
also play a role in arterial remodeling due to elevated blood pressure. Progenitor cells are 
present in native arteries [149-151]. Throughout the G&R time course, the amount of 
CD34 stain in the arterial walls of P-Ao did not change significantly from that of the 
control [Fig. 5.15 (A, B)]. However, the percent of CD34 in the MCA significantly 
increased 2.5 fold by week 4 and remained elevated [Fig. 5.15 (C)]. Unlike the 
progenitor cells, accentually zero macrophages were present in the control arteries. 
Macrophages were not observed in any of the MCA arteries after the onset of 
hypertension as well. However, in the P-Ao and LAD, a significant increase in MAC387 
was observed at week 2 [Fig. 5.16 (A, B)]. In both artery types the relative macrophage 
content decreased by 4 week. Unique to the LAD, macrophage content was statistically 
elevated by week 8 [Fig. 5.16 (C)].  
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FIGURE 5.12. (A, B, C) Percentage of collagen (mean ± SEM) in the AP, LAD and 
MCA Mean ± SEM. Time 0 represents the surgery control. (B, C) Collagen was 
significantly increased in the LAD and MCA at weeks 2 and 4 (* p < 0.05, unequal two 
sample ttest). (B) Although not significant at week 6, collagen was significantly 
increased in the LAD at week 8 (* p < 0.05, unequal two sample t-test).  
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FIGURE 5.13. Percent of positively stained SMA in the P-Ao, LAD and MCA wall 
over time Mean ± SEM. * p < 0.05, unequal two sample t-test 
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FIGURE 5.14. Percent of elastin (VVG stain) in the wall of P-Ao, LAD and MCA 
Mean ± SEM. Week 8 in the P-Ao and week 4 in the LAD are significantly higher than 
the normotensive control. * p < 0.05, unequal two sample t-test 
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FIGURE 5.15. Percent of positive CD34 within the arterial wall of the (A) P-Ao, (B) 
LAD, and (C) MCA at each experimental time point. The average hematopeoitic 
progenitor cell ratio is below 2% for all arteries. (C) The MCA shows a slight but 
statistically significant increase in positive stain ratio from 4 to 8 weeks. * p < 0.05, 
unequal two sample t-test  
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FIGURE 5.16. Percent of positive MAC387 within the arterial wall of the (A) P-Ao, 
and (B) LAD at each experimental time point. There were no detectable macrophages in 
the MCA.  The average macrophage content is below 2% for all arteries. (A, B) At week 
2 both arteries statistically have express more macrophages then the control. (B) The 
LAD also significantly elevated macrophage content at weeks 6 and 8. * p < 0.05, 
unequal two sample t-test  
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 The cumulative arterial responses mentioned above can also be observed 
geographically using representative images. For example, Figure 5.17 illustrates nearly 
concentric increase in wall thickness, and the distribution of SMA (red), elastin (green), 
and nuclei (blue) in a normotensive, 2 week hypertensive, and 8 week hypertensive P-
Ao. It was observed in most P-Ao that initially the neointima consists of non-contractile 
cells (SMA-negative). These intimal cells then take on a contractile apparatus. Similarly, 
Figure 5.18 illustrates SMA stained LAD and MCA over the hypertensive period 
studied herein. Although these few images cannot capture all of the observed structural 
responses of all 41 animals, as seen in Figures 5.8 - 5.16, one can observe the thickening 
(of the adventitia, media, and intima), increase in SMA, general morphology, and 
relatively constant cell density in the LAD [Fig. 5.18 (A-E)]. In addition, one can see for 
the MCA moderately constant mean wall thickness and reduction of intimal space [Fig. 
5.18 (F-J)]. Note that the intima was classified as material between the IEL and the 
lumen. Thus, increased undulation as observed in the normotensive arteries [Fig. 5.18 
(F)] will result in greater intimal thickness. 
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FIGURE 5.17. Smooth muscle actin stain (red) showing an increase in SMCs in the 
proximal aorta after 2 weeks of increased blood pressure. By 8 weeks the overall medial 
thickness does not change much, but the neointima increases in thickness. Blue indicates 
nuclei and green indicates elastin.  
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FIGURE 5.18. Representative images of the left anterior descending coronary arteries 
(LAD) and middle cerebral arteries (MCA) from the same pig after 0, 2, 4, 6 and 8 
weeks after increasing the MAP above 150 mmHg.    
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FIGURE 5.18 continued. 
 
 
 All arteries were stained with the hemopoietic progenitor cell (HPC) marker 
CD34. In addition to being a HPC marker, CD34 has been reported to be a vascular 
endothelial cell marker for small arteries [152]. Also, when these endothelial cells 
proliferate they down regulate the CD34 protein while maintaining the maintaining the 
CD34 mRNA [152]. HPC were observed in the adventitia and media of normotesive P-
Ao, and, to a greater extent, in hypertensive P-Ao at 2 weeks. By week 6 HPC were also 
noticed in the intima of hypertensive P-Ao. CD34+ cells were detected in the 
endothelium and a few throughout the media and adventitia in the LAD and MCA of 
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normotensive and surgery control arteries [Fig. 5.19 (A, F)]. Interestingly, at 2 weeks 
endothelial cells in the LAD and MCA were not all positive for CD34, suggesting a 
possible switch to a more proliferative phenotype. By week 4 the endothelium is CD34+ 
again. In addition, hematopeitic/endotelial cells are seen primarily in the intima and 
adventitia of LAD and in the intima and media of MCA. The overall density of 
hematopoeitc cells decreases in the LAD by week 6 and even more so by week 8. 
However, presence of hematopoetic cells in the intima, media and adventitia of the MCA 
remain after 6 and 8 weeks of elevated MAP.   
 Extravasation of progenitor cells into the neointimal space corresponds with a 
lack of SMA expression. For example, Figure 5.20 illustrates two serial sections of an 8 
week HT P-Ao, one stained for SMA and the other for CD34; neointimal cells were 
positive for CD34 but negative for SMA. Likewise, neointimal cells positive for CD34 
and negative for SMA were also observed in the LAD. It is important to note, however, 
the majority of neointimal cells negative for SMA were not CD34 positive.   
Arteries were also stained for a macrophage marker, MAC387. Macrophages 
were present in the adventitia and media of the P-Ao and LAD at 2 weeks [Fig. 5.21]. 
Macrophages were also observed, primarily in the adventitia and intima still, at weeks 4, 
6 and 8 in these artery types. There were no macrophages seen in the MCA at any time 
point. 
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FIGURE 5.19. Representative images from the LAD and MCA stained red for 
hematopoietic progenitor cells (HPCs), blue for nuclei, and autofluorescent green for 
elastin and platelets.  
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FIGURE 5.19 continued.  
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FIGURE 5.20. Serial sections of a 4 week HT P-Ao stained for (A) SMA or (B) CD34. 
Red indicates positive SMA staining in A and A.1 and positive staining for CD34 in B 
and B.1. Magnified neointimal images of the yellow boxed region in A and B (i.e. A.1 
and B.1 respectively) are shown on the right. Note, the vertical green line in B is due to a 
fold in the artery sample. 
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FIGURE 5.21. Several macrophages (green) were observed in the (A) A-Po and (B, C) 
LAD after 2 weeks of elevated blood pressure. Macrophages were located primarily to 
the adventitia and intima either artery type. Blue indicates nuclei. 
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Discussion 
 The results reported here are consistent with the well known observation that 
hypertension causes structural changes within the arterial wall, often primarily 
manifesting as a thickened media. Such findings were extended herein by documenting 
differential progressive changes in elastic (proximal thoracic aorta) and muscular 
(coronary and cerebral) arteries in the same animals during the progression of 
hypertension due to an aortic coarctation. In particular, we quantified changes in the 
extracellular matrix, specifically collagen and elastin, as well as cellular composition. 
We found that the degree and time course of arterial remodeling depends, in part, on the 
location of the vessel within the arterial tree. Compared to the elastic artery (P-Ao), the 
inner radii and thicknesses in the muscular arteries (LAD and MCA) fluctuated more, 
cell density over the entire wall was greater, and collagen ratios were constant despite 
the marked geometric alterations. Nonetheless, differences within the muscular arteries 
were observed. For example, the MCA initially lost overall contractility whereas the 
LAD showed an increase; this may be due to the increased proximity of the LAD to the 
myocardium. Moreover, the LAD significantly increased in wall thickness and inner 
radius whereas the MCA does not. 
 Many animal models support the clinically observed identification of 
hypertension as a risk factor for atherosclerosis (e.g.,[153, 154]). Among other factors, 
the role of increased macrophage activity within the wall may be central to both the 
hypertension-induced structural changes and the associated acceleration of 
atherosclerosis [84]. Angiotension II (ANG-II) induced hypertension in rats results in a 
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significant increase of macrophages in the adventitia of the aorta within 7 days [16, 155]. 
In spontaneously hypertensive rats, the presence of subendothelial macrophages was 
maximal in the carotid artery, less in the aorta, and nonexistent in the renal artery [156]. 
In our porcine coarctation model of hypertension, we observed several macrophages in 
the adventitial and neo-intimal spaces of the P-Ao and LAD starting at 2 weeks, but 
none in the MCA even after 8 weeks. Macrophages were conserved to the adventitia and 
neointimal spaces in both the P-Ao and LAD; only a few macrophages were observed in 
the media at week 8. These findings suggest that monocyte infiltration through both the 
lumen and vaso vasorum (or peri–adventitial tissue) may play a role in the progression 
of hypertensive induced remodeling of the arterial wall.  
Circulating hematopoietic progenitor cells (HPCs) may localize to damaged 
arterial tissue through a chemotactic response. Moreover studies over the last decade 
show the adventitia in fully developed blood vessels contains residential HPCs [149-
151]. These HPCs are capable of migrating into the media and intima. Herein we also 
document the presence of HPCs in the normal and hypertensive aortic wall. An increase 
in HPCs is seen in wall of the P-Ao by 2 weeks of hypertension, the LAD by 4 week of 
hypertension, and the MCA by 4 weeks of hypertension. Others have reported bone 
marrow derived HPCs in pulmonary blood vessels following hypoxia [157, 158] or 
monocrotaline induced pulmonary hypertension [159]. Colocalization of vWF+ with 
CD34+ markers suggests hematopoietic progenitor cells gave rise to these new 
endothelial cells [160, 161] or, and maybe more likely, since endothelial cells are 
CD34+ in normotensive controls, the CD34 marker is expressed in vascular endothelial 
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cells of small arteries [152]. An increased compressive radial stress, such as those 
experienced by the arteries during hypertension, has been shown to promote the 
expression of smooth muscle-like proteins (αSMA and SM-MHC) in bone marrow 
stromal cells [162]. Likewise, HPC in the adventitia and media of the P-Ao also co-
express αSMA. However, we observed most HPCs in the intima, media, and adventitia 
of the LAD and MCA do not co-express αSMA. Therefore, some contractile cells in the 
wall of hypertensive P-Ao appear to arise from a hematopoietic origin.  
Within the arterial wall there is a mixture of macrophages, HPC, fibroblasts, 
endothelial cells, etc., and three primary structurally significant constituents. These are 
constituents are elastin, fibrillar collagen, and SMCs. We show herein for the mini-pig in 
normal conditions the percent of collagen, elastin and SMC (indicated by αSMA) is 9.5, 
48.9, and 36.4 for the P-Ao, 52.2, 8.6, and 32.4 for the LAD, 40.3, 2.8, and 40.7 for the 
MCA. One can assume that the rest of the mixture is due to proteoglycans, aqueous 
material and other cells. After 8 weeks of elevated blood pressure the fractions of these 
constituents are different; that is the percent of collagen, elastin, and SMC is 31.6, 70, 
38.5 for the P-Ao, 56, 5, 41.8 for the LAD, and 44, 2.8, and 40.3 for the MCA. Note that 
the sum of the constituents of the 8 week P-Ao and LAD are over 100%; therefore, 
assuming no two constituents can occupy the same space we suggest this overestimate 
may be a product of using serial images samples when staining. That is, to determine 
collagen we used PSR, for elastin VVG, and for SMC we used SMA, thus requiring 3 
separate samples with slightly different geometry and composition. In addition, in order 
to get better resolution we took at least 2 images of wall sections. However, this means 
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we may miss some of the spatial variation within each sample for any given stain. 
Nonetheless, knowing the mass fractions of each will be instrumental in mathematically 
modeling arterial behavior during G&R. 
The results presented herein suggest that fibrillar collagen production in response 
to elevated blood pressure depends on the type of artery. The MCA and LAD had 
insignificant changes in the total amount of collagen whereas the relative amount of 
collagen increased significantly by week 4 and remained elevated in the P-Ao. In 
addition the cells in the P-Ao may slightly enlarge in preparation for collagen 
production; then after collagen has been laid down the arterial cells may proliferate. 
Although not statistically significant, cell density decreased by 5% from the normal 
value at week 2 and then increased by 8% from the normal value by week 4. Therefore, 
we suggest that cell hypertrophy occurs first and then hyperplasia or nuclear ploidy. 
Moreover, although statistically insignificant, in the LAD we see a slight increase of 5% 
in cell density at week 2. Afterward the LAD does not produce more collagen. This 
suggests, rather than hypertrophy in preparation for matrix production, hyperplasia or 
nuclear ploidy occurs first in the LAD. Yet current reports, as to whether hypertension is 
a result of hypertrophy [64, 130, 163, 164] or hyperplasia [165, 166], are conflicting. 
Herein, we show the overall nuclei density remains nearly constant, amid increases and 
decreases in thickness over the growth and remodeling, time course. This implies there is 
a preferred cell density that the artery seeks to maintain.  
In addition to each artery type having a nearly constant cell density over the 
G&R period, the distribution of nuclei within the arterial wall displaced similar trends 
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over the G&R period. A greater nuclei density within the initial 10% of the arterial wall 
[Fig. 5.11] may be due to greater packing density in the intima. That is, the length of 
cells along the luminal surface is in the axial direction allowing for more cells to align in 
parallel. Adventitial cells are also primarily oriented in the axial direction, however, 
space filling matrix (e.g. collagen) also resides in the adventitia. However, the fact that 
the cell count remains elevated and nearly constant within the initial three quarters of the 
P-Ao wall, amongst space filling elastin, indicates that overlapping of the concentric 
SMC layers may also contribute to a greater cell count [Fig. 5.11 (A)]. Unlike the P-Ao 
and LAD, the distribution of nuclei as a function of position trend appears to change 
over time. This may be due to the relatively fewer number nuclei per MCA sample (on 
the order of hundreds rather than thousands for the P-Ao and LAD) and greater density 
(0.005497 versus 0.000127, 0.00378 cells/µm2).    
In response to a sustained increase in pressure, it appears that the arterial wall 
thickens gradually in attempt to restore the intramural stress to homeostatic values [36, 
164]. Herein, the wall of the P-Ao and LAD thickened. For the P-Ao, this increase in 
mass also led to a decreased actin fibers followed by an increase in collagen. Whereas 
for the LAD, the increase in mass did not result in a decrease in total actin fibers; 
likewise an increase in collagen was not observed either. This suggests that these arteries 
responded to elevated blood pressure in two ways: first, by increasing wall thickness 
(possibly to restore hoop stress to normal, as thickness is inversely related to hoop 
stress), second, by laying down new material (e.g. collagen in attempt to the stiffness, 
thus resist the increase in load). Based on the responses for the two types of arteries 
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shown here, it seems that the muscular artery increases in thickness but does not lay 
down material perhaps due to the greater amounts of basal collagen to start with. The 
elastic artery also increases in thickness, then loses contractility, and produces 
structurally supportive matrix. This is consistent with the inverse correlation proposed 
by Stegemann & Nerem, 2003 [57, 167]; that is, increased cell contractility (SMA) often 
associates with decreased cell proliferation and vice versa. Knowing the geometry and 
cellular changes over time can aid in the development of improved computational G&R 
models as well as contribute to clinical and pharmaceutical applications. 
In summary, we suggest that in aortic coarctation models of hypertension, effects 
of increased pressure manifest first in the central arteries and later in distal muscular 
arteries. It appears tissue maintenance via, a loss and then increase of cytoskeleton actin 
fibers, production of fibrillar collagen, production of elastin, hyperplasia or hypertrophy 
with nuclear ploypoid, and recruitment of hemopoeitic progenitor cells and monocytes 
occurs in the elastic aorta. In the muscular coronary, we see similar changes albeit it 
appears actin fibers are recruited and collagen production is only slightly increased in 
order to maintain constant the overall ratio ~55%. In the muscular cerebral artery, 
despite a temporary loss in contractility there is little structural change. Others have also 
observed functional changes occurred in coronary arterioles by 8 weeks following the 
initiation of hypertension [168].  
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CHAPTER VI 
ATHEROSCEROSIS – EXPERIMENTAL FINDINGS 
Overview 
Regional material properties of tissues influence the intrinsic cellular responses 
and vice versa. Atomic Force Microscopy (AFM) was used to measure the pointwise 
modulus of elasticity of healthy aortas and plaques at the micron level. Slices of 
advanced plaque were obtained from a widely used animal model of atherosclerosis 
(ApoE-/- mice). Median asymptotic pointwise moduli were 18.7 kPa and 1.5 kPa for the 
unloaded healthy wall (n = 25) and plaque material (n = 18), respectively. When the 
normal wall was pressurized for testing, two mechanically distinct populations were 
identified by comparison to a normal cumulative distribution, with median asymptotic 
pointwise moduli of 9.8 and 76.7 kPa (n = 16). Most of the plaques behaved like a 
homogeneous linear elastic material and were identified to be lipid-laden through 
histology and immunofluoresecence. Understanding the mechanics and 
mechanobiological factors involved in lesion development and remodeling could lead to 
patient-specific strategies to treat better those lesions that are vulnerable to rupture. 
Introduction 
Apolipoprotein E deficient (ApoE-/-) mice do not express ApoE, an important 
ligand for receptor-mediated removal of lipoproteins from the plasma; lack of ApoE 
causes low density lipoproteins (LDLs) to accumulate within the arterial wall, which 
leads to atherosclerosis. Atherosclerotic plaques in ApoE-/- mice exhibit many 
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characteristics found in humans [169, 170], as, for example, compensatory enlargement, 
medial thinning, and elastolysis [26, 171, 172].  
 Atherosclerotic plaques are complex materials, consisting of aberrant 
accumulations of smooth muscle cells (SMCs), foam cells, collagen, calcium, and 
necrotic debris in advanced human lesions [173]. The distribution and material 
properties of these many constituents can be initiators or indicators of plaque 
vulnerability. For example, many studies suggest that plaques rupture more frequently 
within regions of mechanical stress concentrations, located along the border of soft lipid 
pools (e.g. [174, 175]) or near deposits of calcium [176]. Many such predictions are 
based on continuum models that attempt to account for differences in mechanical 
properties (stiffness) among lumped plaque types: for example, grouping plaques as 
primarily fibrous, lipid laden, or calcified [170, 177]. Yet, in vitro measurement of the 
stiffness of individual constituents within the plaque has not been accomplished using a 
direct method.  
Many autopsy studies have provided important information on the morphology, 
composition, and pathology of plaques, which in turn led to a classification scheme 
advocated by the American Heart Association [178], with subsequent revisions proposed 
by others (e.g., [173, 179, 180]). Efforts are also intensifying to advance medical 
imaging to enable detection of plaque composition (i.e., to distinguish regions containing 
calcium, dense fibrous tissue, lipids, smooth muscle cells, and even increased metabolic 
activity) for purposes of diagnosis and designing interventions [181, 182].  In particular, 
the technique known as elastography is emerging as a potentially useful tool to estimate 
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mechanical strain and stiffness within plaques, though there remains a need for a better 
correlation between plaque composition and stiffness to enable the method to predict 
possible vulnerability [183, 184]. Indeed, this correlation of composition to stiffness 
must be known to infer the structural integrity of a plaque based on any method, which 
would represent a significant clinical advance.  
In addition to the data collected on human lesions, ApoE-/- mice provide a 
unique opportunity to study the natural history of atherosclerotic disease progression and 
to identify underlying molecular mechanisms. Indeed, the ApoE-/- mouse has also been 
used for studying balloon angioplasty and intravascular stenting based on the similar 
procedural success rates and morphology with humans post-intervention [185]. Yet there 
has been little attention directed towards quantifying the mechanical properties of 
plaques in the ApoE-/- mouse, even though computational models can now predict 
stresses in these lesions [186]. Because the area of a typical ApoE-/- aortic plaque is 
only ~100 mm
2
 by 56 weeks [186], one of the challenges in quantifying potential 
regional mechanical properties is the smallness of the associated plaques. 
Therefore, in this chapter we address this need by combing Atomic Force 
Microscopy (AFM), histology, and standard immunofluorescence, to determine plaque 
stiffness in the axial direction, including regional variations within a plaque.    
Methods 
Animal Model. All animal protocols were approved by the Institutional Animal 
Care and Use Committee at Texas A&M University. ApoE-/- breeder mice were 
purchased from Jackson Laboratories and maintained by the Comparative Medicine 
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Program at Texas A&M University for up to 56 weeks. The colony was switched from a 
9% fat chow diet to a western-type diet consisting of 21.2% fat and 0.2% cholesterol 
(Harlan Tekland, Madison, WI) after an initial period of 16 weeks. Heterozygous and 
wild-type mice from a fibrillin-1 deficient colony, with a C57/S129 background, were 
also used to study the mechanical properties of the normal aortic wall. 
Sample Preparation. AFM force-indentation testing was performed on 
circumferential cross-sections of the normal aortic wall and atherosclerotic plaques 
(thickness of 0.5 mm, outer diameter of 0.5 to 1.5 mm).  The suprarenal aorta (i.e., 
between the diaphragm and renal arteries) was harvested by blunt dissection from ApoE-
/- mice at ages ranging from 42 to 56 weeks (n = 13 animals, n = 18 plaques), with at 
least one plaque detected visually in each animal [Fig. 6.1(A)]. Next, the aorta was 
embedded in a 2% agarose gel, just prior to solidification, and then sectioned into 0.5 mm 
thick segments using a vibratome (Vibratome Series 1000, The Vibratome Company, St. 
Louis, MO). Each tubular section was then affixed to a 60 mm diameter petri-dish with 
RP30 instant adhesive (Adhesive Systems, Inc, Frankfort, IL); 1.7 mL of phosphate 
buffered saline (PBS) was then added to the petri-dish to submerge the sample [Fig. 
6.1(B)]. 
 112 
 
FIGURE 6.1. (A) Plaque was detected by gross examination in the suprarenal aorta 
from ApoE-/- mice aged 42 to 56 weeks. (B) The desired aortic section was embedded in 
2% agarose gel, sectioned with a vibratome at a thickness of 0.5 mm, mounted to a 35 
mm diameter petridish, and mechanically tested through nano-indentations in the axial 
direction. 
 
 
 
Aortic samples were prepared from the control mice in a similar fashion, with a 
few modifications. Following blunt dissection, the infrarenal aorta was either embedded 
in 2 % agarose gel while pressurized to approximately 100 mmHg (n = 15 animals, n = 
20 aortic walls; in 5 cases 2 aortic wall samples were obtained from one animal) or 
embedded while unpressurized (n = 30 animals, n = 30 aortic walls). Pressurization was 
maintained by cannulating the proximal aorta (near the renals), injecting dyed agar 
antegrade through the aorta, ligating the distal aorta (near the iliacs), and bringing the 
pressure to 100 mmHg as determined by a connected pressure transducer (Living 
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Systems Instrumentation, Burlington, Vermont). After solidification of the agar by 
cooling to room temperature, the aortic segment was sectioned and affixed to the petri-
dish, and immersed using PBS as described above. 
AFM Testing. Force-indentation data were acquired using a Bioscope System 
AFM (Veeco Instruments, Santa Barbara, CA) equipped with a Nanoscope IIIa controller 
and mounted on a Zeiss Axiovert 100 TV inverted optical microscope (Carl Zeiss, 
Thornwood, NY). A 5-µm diameter spherical tip (borosilicate glass bead) attached to a 
silicon-nitride cantilever having a spring constant of either 60 or 120 pN/nm (Novascan, 
Ames, Iowa) was used to indent the samples. A spring constant of 60 pN/nm allows 
increased sensitivity in the approach curve for softer samples; in contrast, a cantilever 
with a spring constant of 120 pN/nm gives a more accurate response for stiffer samples. 
After laser diode positioning adjustments on the cantilever, deflection sensitivity (i.e. 
probe deflection versus piezo z-position) was determined by acquiring force curves on a 
60 mm polystyrene petri-dish in PBS at 0.5 Hz. Afterward, the sample was located within 
the petri-dish and visualized in real-time using a Zeiss 32X objective and video camera 
(Pulnix, model TM 34KC, Yokohama, Japan). The AFM cantilever tip approached the 
sample at a frequency of 0.5 Hz with a z-scan size of 800 nm (speed of 0.8 µm/s). After 
recording at least 30 consecutive indentation force-depth curves at each location on the 
artery/plaque, the tip was retracted to its original position. Similarly, additional curves 
were recorded over regions 80 x 80 µm
2
 at intervals of about 20 µm achieved using the x 
and y offset controller. To move to a different macroscopic region, the sample and petri-
dish were moved together via the x-y stage controlled by the Nanoscope. The AFM tip 
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was then again brought into contact with the surface of the sample, and force curves were 
acquired over another 80 x 80 µm
2
 region.  This process was repeated until the entire 
region of interest was mapped.  After mechanical testing, a live/dead viability / 
cytotoxicity kit for mammalian cells (Invitrogen, Carlsbad, CA) was used to determine 
the viability of the tissue. 
Histology and Immunofluorescence. A 0.5 to 1.0 mm long aortic section adjacent 
to that tested with the AFM was fixed with 4% paraformaldehyde for 1 hour at room 
temperature, then placed in 30% sucrose overnight at 4° C for cryoprotection. The sample 
was then embedded in “optimum cutting temperature” compound (OCT), flash-frozen 
with liquid nitrogen, and cut into 5-µm thick sections for standard histology and 
immunofluorescence. Serial sections were stained with hematoxylin and eosin (H&E) for 
general morphology, Verhoeff-van Gieson (VVG) for elastin (Verhoeff) and collagen 
(van Gieson), Masson‟s trichrome for collagen, oil red O (ORO) for lipids, von Kossa for 
calcium, alpha smooth muscle actin (αSMA) for contractile cells, and von Willebrand 
factor (vWF) for endothelial cells. Optimal conditions for αSMA stain were 1:100 
dilution of primary antibody (ab5694, Abcam) for 1 hour at room temperature in PBS 
followed by heat induced (pressure cooker) sodium citrate antigen retrieval, then 
exposure to a 1:500 dilution of Alexa Fluor® 594 secondary antibody (Invitrogen, 
A11012) for 30 minutes. Optimal conditions for vWF stain were 1:100 dilution of the 
primary antibody (Abcam, ab6994) for 1 hour at room temperature in PBS, with heat 
induced (pressure cooker) sodium citrate antigen retrieval and then exposure to a 1:500 
dilution of Alexa Fluor® 594 secondary antibody (Invitrogen, A11012) for 30 minutes. 
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Pointwise Elasticity Measurement. AFM force curves were analyzed as described 
in Costa et al. (2006). Prior to sample testing, we recorded the deflection sensitivity in 
PBS using the bottom of an otherwise bare petri-dish. Sensitivity calibration allows 
calculation of the applied force         (nN) derived from the measured cantilever 
deflection d (V) via  
            ,         (6.1) 
where   is the specified spring constant (nN/nm) for the cantilever and    is the 
deflection sensitivity (nm/V); the cantilever deflection was determined in volts from the 
laser position on the photodetector.  
Cantilever deflection resulting from the approach/retraction cycle was monitored 
as a function of piezo movement, namely 
              (6.2) 
where,   is the indentation depth (nm), or deformation of the aortic wall or plaque, and   
is the piezo displacement (nm) during testing. One can calculate the Young‟s modulus 
( ), a measure of material stiffness, using the Hertzian relationship for the indentation of 
a flat, homogeneous, semi-infinite elastic material by a rigid spherical probe [187]. In this 
case, 
        (  ⁄ )( (    )⁄ )√                   (6.3) 
where   is the Poisson‟s ratio, often assumed to be 0.5, and   the radius of the sphere. 
The associated simplifying assumptions to use the Hertzian equation generally do not 
apply for cells or biological soft tissues, however. Therefore, to accommodate for any 
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nonlinearities we calculated the apparent pointwise (  ̃) modulus at each point (i) of the 
approach curve (i.e. for all 512 points along the 800 nm approach curve), that is, 
  ̃  (  ⁄ ) (  
      √   
 ⁄ )        (6.4) 
where   
      
 is the force, in nN, at each data point and √  
  is the indentation depth, in 
nm, at each data point. 
The initial point of contact was first determined by fitting a bi-domain polynomial 
algorithm to the AFM force curve (see [188] for more details). By using a linear least 
squares regression, error was minimized between a line fitted through the pre-contact 
region and a cubic polynomial fitted to the post-contact region of the indentation, √  , 
versus approach force,     , curve. If the goodness of fit (i.e., R
2
 value) fell below 0.9, it 
was typically due to premature convergence on a local contact point caused by a sharp 
change in deflection during contact. To accommodate these cases, and to ensure we 
found the global contact point, we included a loop to the algorithm to change the initial 
contact point incrementally, within 30 points out of the 512 in the indentation curve, until 
the R
2
 value leveled out, typically at around 0.999. A local apparent pointwise elastic 
modulus was calculated from each curve. The mean pointwise modulus and mean force ± 
SEM at each point, for all curves acquired at each location, were then plotted versus the 
mean indentation. All pointwise moduli converged to an asymptotic value after the probe 
attained a certain indentation depth, typically less than 30 nm.  
Statistical Analysis. To minimize noise, we removed pointwise moduli 
corresponding to indentations ≤ 10 nm of the approach curve. A total of approximately 
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750 curves per wall and 1,650 curves per plaque sample were analyzed (i.e., ~30 curves 
per location, ~25 locations per aortic wall sample, and ~55 locations per plaque sample).  
All asymptotic stiffness values for each condition (unloaded aortic wall, pressurized 
aortic wall, or plaque) were examined graphically using histograms [Fig. 6.3]. The data 
were transformed from a right-skewed to a distribution more Gaussian in appearance 
using the natural logarithm. The median was calculated for original data and the median, 
mean, and standard deviation were calculated for original data and data transformed 
using the natural logarithm. Differences in the transformed populations were evaluated 
using an unpaired two-sample t-test.   
Histomorphometry. To correlate the real-time AFM images, obtained during the 
experiment that detailed the tested locations, with the histology/immunofluorescence of 
the adjacent sample, we scaled the histological images using GIMPshop 2.2.8. After 
obtaining the best match, stiffness values were overlaid on the histological images. Due 
to extra handling and occasional loss of sample between the histological sample and 
mechanically tested samples, there were slight geometrical differences.  
Results 
Plaques were grossly noticeable in the suprarenal aorta in all ApoE-/- animals (n 
= 12, 42 to 56 weeks). Plaques were rarely seen in the proximal thoracic aorta and 
infrarenal aorta, however. Figure 6.1 shows the ventral view of a 45.6 week old male 
ApoE-/- aorta as well as a schematic of the subsequent preparation for testing. 
Interestingly, large flat plaques seemed to form eccentrically on the ventral side, whereas 
smaller plaques taking on the shape of blisters protruded into the lumen on the dorsal 
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side. In order to obtain a smooth surface, as is required for accurate AFM indentation 
testing, the soft vessels with inlayed plaque(s) were reinforced with 2% agarose gel and 
sectioned prior to testing.  
After calibration of the AFM probe, the plaque was detected and tested. Figure 
6.2 shows all stiffness curves collected from 52 locations on a representative plaque plus 
the associated histology / immunofluoresence. Most of the pointwise moduli curves are 
only depth dependent for the first 10 nm. This early decrease in stiffness may be due to 
noise as the probe transitions from fluid to a sample surface with slight irregularities 
(Elkin et al., 2007). The plaque material shown here appears very soft and almost 
linearly elastic. Therefore, the asymptotic pointwise moduli were used to evaluate the 
correlation between mechanical properties and plaque structure. By superimposing the 
histological images onto the asymptotic stiffness representation, localized increased 
stiffness near the shoulders of a pure lipid region (ORO) were seen. In addition, stiffness 
values near 9 kPa corresponded approximately with the few contractile cells (SMA). 
Positive vWF was found in the endothelial layer lining the lumen. Some positive 
intraplaque staining for vWF was present in acellular areas, as indicated by DAPI 
counter-staining. A fairly intact internal elastic lamina may suggest the primary cell 
types are circulating monocytes and proliferating endothelial cells and not smooth 
muscle cells.  
Variation in stiffness can be accurately mapped onto the mosaic of AFM images 
of the tested plaque surface [Fig. 6.2(B), Fig. 6.3]. The plaque sample adjacent to the 
tested surface was used for histology and immunofluorescence. Histological processing 
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requires a loss of approximately 100 microns from the sample. Therefore slight 
geometrical differences arise due to the physical gap between the tested plaque surface 
and the stained plaque surface. After resizing, however, the histological sample 
generally aligned with the AFM image [Fig. 6.3]. Figure 6.3 shows a representative 
plaque from a 45.6 week old male ApoE-/- mouse. All the asymptotic pointwise moduli 
were below 10 kPa, except at 2 locations near the plaque cap on the right, where the 
values were 15 and 27 kPa. 
Stiffness values were also found for the aortic wall in wild-type and 
heterozygous mice of the same background as the ApoE-/- mice. Figure 6.4 shows the 
natural log transformation of all the asymptotic stiffness values acquired over the normal 
aortic wall (unloaded and loaded). The actual asymptotic stiffness values display as a left 
skewed distribution [Fig. 6.4 (A), (C)]. The median stiffness value of the actual data 
corresponds to the back transformed value of the natural log mean. Comparing all of the 
stiffness values from the unloaded and loaded walls shows that the unloaded group is 
significantly stiffer (axially in compression) with median values of 18.7 and 11.4 kPa, 
respectively (p = 0.0015). Stiffness of the unpressurized walls exhibits a predominately 
right-skewed distribution with a long tail. Stiffness distribution of the pressured wall is 
more bimodal, with median values of 9.8 and 76.7 kPa. 
 
 
  
 120 
FIGURE 6.2. (A) Point-wise modulus versus indentation depth (symbols) and the 
calculated asymptotic stiffness (solid line) are shown on the same scale (0-15 kPa for the 
modulus and 0-200 nm for depth). (B) Overlaid topographical images, acquired via the 
inverted optical microscope and CCD camera, detail the outline of the opaque ApoE-/- 
plaque, arterial wall, mechanically tested locations, and asymptotic pointwise modulus 
value at these locations. (C) Histological examination of the face adjacent to the one 
tested reveals a lipid laden (ORO) cellular plaque with no calcifications (Von Kossa). 
This plaque appears fairly collagenous (TRI) with fragmentation and straightening of the 
elastic lamina (VVG). Cells in the plaque and adjacent wall take on a less contractile 
phenotype (SMA). Endothelial cells line the luminal surface (vWF) as well as regional 
intraplaque expression.  
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 FIGURE 6.2. continued. 
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FIGURE 6.3. Representative plaque overlay showing the mechanically tested locations 
and there stiffness values mapped over the histology samples and the original AFM 
image. The original AFM image is displayed in the upper left corner followed by the 
various histological stains overlaid (i.e. Oil Red O (ORO), alpha smooth muscle actin 
(SMA), von Kossa, hemotoxylin and eosin (H&E), von Willebrand Factor (vWF), 
Verhoeff-van Gieson (VVG), and Massons trichrome (TRI).  
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FIGURE 6.4. Histograms of the asymptotic axial compressive stiffness over the wall of 
(A, B) unloaded (n = 25 animals) and (C, D) pressurized to ~100 mmHg (n = 16 
animals) normal arteries. (A, C) Distributions of stiffness were originally right-skewed 
(bin size of 20 kPa, skewness of 8.6 and 3.2 for unloaded and loaded respectively); (B, 
D) after a natural log transformation, the distributions are Gaussian (bin size of 0.4, 
skewness of -0.3 and 0.3 for unloaded and loaded respectively). (C) The normal 
distribution constructed from the mean and standard deviations is outlined in red for the 
softer and stiffer populations of the pressurized aortas, respectively. Compressive axial 
stiffness of the unloaded wall is statistically different from the pressurized wall 
(unpaired two-sample t-test, p = 0.00042). 
 
 
 
For all plaques, 85.6% of the asymptotic stiffness values were below 5 kPa. 
Figure 6.5 shows the stiffness of the plaque compared to the normal wall. The 
maximum stiffness value from all plaques is 37.2 kPa; the small cluster near this value, 
with median stiffness of 24.3 kPa, is attributable to a calcified region from a single 56 
week female plaque out of the 18 plaques examined. Collagen is present in these 
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plaques; however, collagen does not seem to have a significant effect on the axial 
compressive stiffness. Lack of increased stiffness may be due to the altered organization, 
cross-linking, or lower density of collagen fibrils present in these plaques. Moreover, the 
plaque materials from the 18 plaques studied herein appeared more mixed or 
homogeneous with the predominate one being lipid-ladened.  
 
 
 
 
FIGURE 6.5. Histograms of the asymptotic axial stiffness values of plaques (n = 18 
plaques, n = 12 animals). (A) Originally the distributions were right-skewed (inlay) (bin 
size 5 kPa, skewness of 5.36); (B) after a natural log transformation the distribution is 
Gaussian (bin size 0.2, skewness of 0.58). Axial stiffness of plaques are statistically 
different than normal wall (unloaded, unpaired two-sample t-test, p < 0.0001; 
pressurized, unpaired two-sample t-test, p < 0.0001). 
 
 
 
In the wall of the pressurized artery of the control mice there appeared to be at 
least two mechanically different materials. Figure 6.6 shows the two populations of 
material stiffness observed in pressurized arteries. Through a cumulative distribution 
display of the empirical pressurized stiffness we see there is a population that deviates 
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from normality [Fig. 6.6]. Likewise, computing the probability density estimate based on 
a normal kernel function with a bandwidth of 0.25 illustrates a second stiffness 
population. Separating these populations at 43 kPa and plotting Gaussian distributions 
based on their standard mean errors, 12.3 ± 0.59 kPa and 76.4 ± 3.22 kPa for the softer 
and stiffer populations, respectively is shown in Figure 6.3(C).  
 
 
 
FIGURE 6.6. The empirical cumulative distribution of the natural log transformed 
asymptotic stiffness of (A) unloaded arteries, (B) loaded arteries and, (C) plaques are 
shown by dashed curves. (A, B, C) The normal cumulative distributions for each case 
are shown by solid curves. (D, E, F) The kernel smoothed density estimate based on a 
normal kernel function further suggests a second stiffness population in (E), the loaded 
case. For the loaded wall, the disparate stiffnesses are between approximately 43 and 
150 kPa. The peaks of the density estimates are thus 34.5 kPa for the unloaded wall, 9.1 
and 71.0 kPa for the loaded wall and, 1.4 kPa for the plaque. 
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Figure 6.7 shows that plaques from males and females are not statistically 
different. Both genders range from 42 to 56 weeks with slightly more plaques tested 
from females than males, n = 11 and n = 7, respectively. Males and females both had 
fairly large lipid laden plaques with median stiffness of around 1.45 kPa.  
 
 
 
FIGURE 6.7. Stiffness from all (A) male and (B) female plaques. The median value was 
(A, right inlay) 1.41 kPa for male plaques and (B, right inlay) 1.47 kPa for female 
plaques. Using the log transformation to compare these distributions revealed they were 
not statistically different (p = 0.33, unpaired two-sample t-test).  
 
 
 
Discussion 
Using a 5-µm diameter spherical AFM tip, we were able to quantify regional 
material properties within cross-sections of atherosclerotic plaques from the suprarenal 
aorta of ApoE-/- mice. The size of the tip was chosen to allow an averaged response of 
the mechanical properties without compromising the specificity of individual structural 
components within the atherosclerotic plaque. Previous techniques used to characterize 
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plaque components include uniaxial testing of 31.7 x 1.2 mm
2
 human aortic intimal 
plaques lumped into 3 categories (i.e. cellular, hypocellular, and calcified; [189]), cyclic 
compression and stress-relaxation testing on 5 x 5 mm
2
 plaque samples [190], and 
torsional rheometer testing on synthesized lipid pools 0.3 to 1 mm thick [189]. Each of 
these techniques required either synthesizing plaque material or removing the plaque 
from its natural configuration and treating it as a homogenized (lumped) material. Yet, 
the complexity in geometry and composition (fibrous tissue, fatty substances, smooth 
muscle cells, elastin fragments, and calcium deposits) demands methods that can 
discriminate better the individual contributions of the different constituents. Indeed, 
stress analyses reveal that perhaps the most important aspect of plaque properties may be 
material discontinuities – that is, the close proximity of stiff and compliant materials, 
which lead to stress concentrations [176].  
The plaques from ApoE-/- mice studied here consisted primarily of large lipid 
laden pools having an associated median stiffness of 1.5 kPa and thin cap. Moreover 
these plaques were not ruptured before testing. Plaque rupture is a complex mechanical 
process dictated by plaque composition and morphology as well as the applied loads. 
Using computational models, Finet et al. (2007) [191] show that a slight increase in 
stiffness in a lipid core (from 1 kPa to 2-30 kPa) results in mechanically stable plaques 
(where the peak cap stress is brought below the 300 kPa threshold assumed for rupture 
of collagen). Using computational stress analyses, Vengrenyuk et al. (2010) [186] 
calculated peak circumferential stress in non-ruptured ApoE-/- plaques to be higher than 
the estimated rupture threshold of humans (minimum 300 kPa, average 545 kPa). 
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Therefore, despite having a thin cap and large lipid pool, the lack of rigid inclusions 
(calcification) was suggested to render the plaques relatively stable.  
Despite a lack of information on exact mechanisms and signaling pathways for 
force sensing and transduction, it is now evident that cells sense the stiffness and 
geometric features of their substrates and respond accordingly [4, 192-195]. It has been 
proposed, nonetheless, that a cell can sense its mechano-environment through local 
adhesions (e.g., cadherins or integrins) by measuring either the strength or displacement 
of these adhesions by a given force [4, 192]. Cells respond to their environment through 
integrin clustering, strengthening of integrin-cytoskeleton linkages, biochemical 
signaling, and even remodeling of the extracellular matrix [4, 192, 193]. Moreover, cells 
can change their morphology (e.g., round for soft and spread out for stiff substrates), 
cytoskeletal organization (around the perimeter for soft and at focal adhesions for stiff), 
and stiffness (within a range) based on that of the substrate [2, 192, 193, 195]. Matrix 
stiffness also aids in proper differentiation of mesenchymal stem cells [196]. Because 
cells control the properties of evolving atherosclerotic plaques, it is thus important to 
know regional plaque mechanical properties which influence the associated adherent cell 
responses.  
The main structural components of a normal aorta are collagen, elastin, and 
SMCs, in order of decreasing stiffness. For example, using a scanning micro-indentation 
tester, Masumoto et al. (2004) [197] found the radial stiffness of the elastic lamina and 
smooth muscle layer of an unloaded porcine aorta to be 180 and 50 kPa, respectively. 
Oie et al. (2009) [198] used a tactile mapping system and found the axial stiffness of the 
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media (comprised of SMCs and collagen fibrils) to be 17.0 ± 9.0 (mean ± SD) kPa and 
that of elastin to be 69.0 ± 12.8 kPa.  In contrast, Young‟s moduli of water-swelled 
collagen sheets having collagen concentrations of 12% or 41% were found to be 137.6 ± 
32.2 and 426.8 ± 136.4 kPa, respectively. Moreover, other groups report collagen to be 
~1000 times stiffer than elastin [199]. Oie et al. (2009) [198] thus suggest that the medial 
stiffness 17.0 ± 9.0 kPa results from a low density of collagen. Recalling that one 
possible function of collagen in a pressurized artery is to limit over-distension during 
transient over-loading, thus protecting elastin and SMCs from damage, collagen 
probably contributes little to the overall stress-strain response of the aorta at low 
pressures. Indeed, previous studies suggest that collagen fibers contribute minimally to 
residual stresses (or strains) [200]. At high pressures, however, collagen fibers straighten 
and carry much of the intramural load [83, 199].  
The bimodal distribution of axial stiffness revealed by Figures 6.4 and 6.6, with 
medians of 9.7 and 76.7 kPa, may similarly suggest two material populations within the 
modestly pressurized normal aortic wall. Albeit not statistically significant, a plot of 
stiffness versus location reveals most stiff values lie within the inner two-thirds of the 
aortic wall. This observation suggests the stiffer population may be due to elastin, since 
collagen primarily resides in the adventitia and elastin in the media. Costa et al. (2006) 
[188] also reported a bimodal distribution of stiffness for individual cells. Whereas they 
used nanometer-diameter tips, able to distinguish cytoskeletal filaments (5.6 ± 3.5 kPa) 
and cytoplasm (1.5 ± 0.76 kPa), we used a micron-diameter tips and were able to 
distinguish material within the smooth muscle layer (thickness 10.1 ± 4.7 µm, mean ± 
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SD) from the elastic laminae (thickness 6.2 ± 2.1 µm) in an unloaded wall section (total 
thickness 136.6 ± 22.9 µm). Excluding the upper 5 % due to a small cluster of stiffness 
values at ~175 kPa, stiffness ranged from 0.5 to 90 kPa with a median of 18.9 kPa for 
the unloaded aorta. In agreement with previously reported material properties, we 
suggest that the upper range is due to elastin, the middle range due to a mixture of SMC 
and unloaded collagen, and the lower range may reflect cytoplasmic material. In the 
samples with a fixed pressure of 100 mmHg, analyses indicated two significantly 
different populations of material with moduli of 12.3 ± 0.59 and 76.4 ± 3.22 kPa. Yet 
similar to the unloaded case, excluding the upper 5 %, stiffness ranged from 0.8 to 94 
kPa with a median of 11 kPa for the pressurized aorta. We suggest the dichotomy in 
material populations that arose when the vessels were pressurized may have been due to 
an increase of lamina stiffening resulting from elastin straightening. Of course, 
circumferentially oriented fibers (e.g., collagen and elastin) may not be load-bearing in 
the unpressurized samples.   
In plaques, cell contractility appeared to be absent in soft regions as indicated by 
the lack of αSMA staining. Rather, these plaques appeared to be dominated by lipids, 
with over 90% of the asymptotic values of stiffness less than 10 kPa [Fig. 6.5]. The 
correlation between the cell function (i.e., contractility) modulated by environmental 
stiffness has been previously observed. For instance, minimal stress fibers form in cells 
grown on soft surfaces (Young‟s modulus of 10 kPa) whereas many stress fibers form on 
stiff surfaces (Young‟s modulus of 100 kPa) [201, 202]. We also found, at the tissue 
level, the mixture of collagen, elastin, and SMCs in the wall of a normal aorta had a 
 131 
compressive axial stiffness around 18.9 kPa, which is well above that of the lipid laden 
plaques. Histology confirmed high lipid content in the plaques as well as straightening 
and fragmentation of the elastic lamina, a low collagen content, a faint layer of 
contractile cells on the luminal face, with expression of vWF lining the lumen [Fig. 6.2]. 
Thus without cell contractility and much of the structural matrix proteins that reside in 
the wall of normal arteries, stiffness values appeared to be dominated by lipids abundant 
in the plaques. 
Interestingly, calcification in the intimal space is typical of advanced lesions in 
humans. In the ApoE -/- mice tested, only one of the 18 lesions exhibited even minimal 
calcification. Therefore, to better represent the heterogeneity of lesions seen in human 
plaques in aortic lesions within the ApoE-/- mouse population (fed a western diet) 
additional measures could be taken. For example, dietary supplements of vitamin D, 
calcium, or warfarin have been shown to increase vascular calcification (Atkinson, 
2008). In addition, SMC apoptosis as well as matrix Gla protein (MGP) and 
osteoprotegerin (OPG) deficient models have also been shown to increase vascular 
calcification ([203-205], respectively).  
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CHAPTER VII 
CONCLUSIONS  
 
In Chapter III we introduce a novel Agent Based Model (ABM) of which was 
designed to be coupled with the Constrained Mixture Model (CMM). A semi-objective 
scoring regime is introduced as a means to gain confidence in the ABM rules derived 
from the literature. A parameter sensitivity analysis was performed on the ABM 
parameters in order to determine proper bounds. Lastly we showed the ABM and CMM 
are stable in homeostatic conditions amongst transient blips in blood pressure. Chapter 
IV applies the CMM and ABM to predict arterial changes in biochemical concentration 
as well as salient features such as geometry, mass of elastin, smooth muscle, and 
collagen, and circumferential stress, in response to hypertension. These predictions seem 
to be within the range of experimental finding. Thus we established the foundation of 
these models, which can be extended through model coupling to create a fully multi-
scale model.  
In Chapter V we used an aortic coarctation model of hypertension to quantify the 
arterial responses to hypertension. We found the changes in artery structure as a 
response to sustained elevated blood pressure differs in the aorta, coronary and cerebral 
arteries. Overall tissue maintenance seems to occur first in the aorta, thickening in the 
coronary, and little change in the cerebral.  In summary, over the 8 week time course, the 
aorta thickens, loses contractility, and recruits hematopoietic progenitor cells and 
monocytes at week 2. At week 4 the relative collagen content in the aorta goes up. By 
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week 8 the collagen content and thickness are still up, however the contractility is back 
to normal. In the aorta there was little change of the inner radius, cell density or elastin 
throughout the 8 weeks. In the coronary, by 2 weeks not only had the thickness increased 
but the inner radius had also increased. At week 4 the density of hematopoietic 
progenitor cells and monoctyes, in the coronary, had increased. By 8 weeks the 
thickness, inner radius and contractile fibers are still up. In the coronary there was little 
change in the relative cell density, collagen and elastin content. Unlike the aorta and 
coronary arteries there was little significant change in the cerebral artery. The 
contractility slightly decreased at weeks 6 and 8, and the cell density decreased at week 
6, but these metrics returned to normal by 8 weeks. It is worthwhile to note that common 
to all the arteries the packing density (or nuclei/area) and elastin remained nearly the 
same at all time points. 
In conclusion, the onset and progression of arterial remodeling is artery and 
location dependent. That is, the remodeling may also depend on the variations within the 
artery type (e.g. the coronary and cerebral are both “muscular” arteries but even at 
normalcy the structure and ratio of elastin, collagen and muscle are different) as well as 
variation between arteries types. In addition, depending on the location the environment, 
loads, tethering, etc. may be vastly different. Therefore, the work presented in Chapter V 
brings us one step closer to understanding sources of mass accumulation and the time 
progression of arterial remodeling to elevated blood pressure. 
In Chapter VI, we proposed a novel technique for testing and quantifying the 
material behavior of plaques ex-vivo. Out of the 18 plaques examined, 15 were highly 
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lipid laden, 2 were more fibrotic, and only one of the fibrotic plaques showed slight 
calcification. The results suggest a median axial compressive stiffness value of 1.5 kPa 
for the lipid regions in plaques. Regional mechano-morphological information of 
plaques is essential for computational analysis. However, for the most part ApoE-/- 
plaques appear to lack distinct material heterogeneity. Microcalcified fibrotic plaques 
need to be induced for aortic ApoE-/- plaques to be considered a representative model 
for human plaques. The work presented here narrows the knowledge gap on the 
connection between the structure and mechanical properties of plaques and the normal 
aortic wall.  
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